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Despite recent reports of declining prevalences of malaria infections in most parts of 
the world, the disease remains one of the most frequent causes for death in children 
under five years of age in Sub-Saharan Africa. Especially children living in countries 
that are holoendemic for malaria, with high parasite transmission during the whole 
year are inescapable exposed to the parasite vector Anopheles. As severe courses 
of Plasmodium falciparum malaria are common in children, diagnostic and treatment 
should be quick and appropriate. But by the way of contrast patients with suspected 
malaria are often rather treated presumptively as the health infrastructure lacks in 
laboratory equipment. To prevent missing sick children in poor medical settings and 
to avoid over-treatment, diagnostic algorithms could be a basis for evidence-based 
decision making. 
 
1.1 Morbidity and Mortality of children in Africa 
Every year ten million children under five years of age die worldwide due to diseases 
that could have been treated with medication or prevented by a vaccination. The 
highest death tolls for children are documented for the African continent, whereby the 
risk of death is the highest in the first month of life. Fourty-three percent of infant 
mortality cases are found in the neonatal period (≤ 28 days of life). The main causes 
for death are age-dependent. While perinatal infections, early births, low birth weight, 
asphyxia and birth trauma account for the majority of fatalities in the neonatal period, 
in the postnatal period respiratory infections, malaria and diarrhoeal diseases are to 
the fore (World Health Organization 2012a).  
For the “World Health Organization (WHO) Millennium development goal (MDG) 
region Sub-saharan Africa”, the ‘under-5 mortality rate’ was 109 per 1000 live births 
in the year 2011. In Ghana figures were lower with 78 per 1000 live births, but still 
above the global average of 51 per 1000 live births (World Health Organization 
2012a). The United Nations International Children’s Emergency Fund (UNICEF) 
ranked Ghana’s under-5 mortality rate on position 46 out of 193 countries in 2008, 
whereby position one reflects the highest under-5 mortality rate (Unicef 2010). In 
most developing countries, more than two thirds of events of deaths are due to five 
common diseases or conditions: Respiratory infections, malaria, diarrhoea, 
malnutrition and measles (World Health Organization and Ghana Office 2004).In 
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Ghana Malaria accounts for 26% of deaths in children under five years of age in 
2008, followed by prematurity with 12 %, pneumonia with 10% and birth asphyxia 
with 11% (World Health Organization 2010a).  
Malaria is known as a major cause of death in African children for a long time and is 
still liable for one in five death cases on the African continent. Each year 300 to 500 
million people worldwide become infected with malaria parasites, more than 75% of 
these infections occur in African children under five years of age (Roll Back Malaria 
Programme 2004). However, in the last decade there is increasing evidence that the 
amount of malarial infections in sub Saharan Africa decreases (Guerra et al. 2008, 
Nyarango et al. 2006, Okiro et al. 2007, Sharp et al. 2007).  
 
1.2 Malaria  
Malaria is a protozoan infection of red blood cells transmitted by the bite of a blood-
feeding female anopheline mosquito, in Africa usually Anopheles gambiae or A. 
funestus (Cook and Zumla 2009a). Of the over 200 known plasmodium species five 
are recognized to be pathogenic to humans as malaria parasites. The four most 
common species of human malaria parasites are P. vivax, P. ovale, P. malariae and 
P. falciparum, which has the greatest impact in terms of mortality. Recently,P. 
knowlesi has also been found to be able to infect humans (Jongwutiwes et al. 2011, 
Khim et al. 2011). The life cycle of Plasmodium is complex, as the parasite needs 
two hosts, the mosquito vector and a vertebrate host. In the human host, the cycle 
comprises of a liver- and blood stage and involves several phases of maturing of the 
parasite. While most of the parasites asexually replicate in the blood vessels, a small 
fraction differentiates into male or female sexual forms, which can be taken up by a 
female mosquito, undergo sexual reproduction in the midgut of the anopheles (Cook 
and Zumla 2009b). 
 
According to estimations of the United Nations, young children in the age of 5 years 
or below from holoendemic areas in Africa have between 1.6 and 5.4 episodes of 
malarial fever each year (Murphy and Breman 2001). In highly endemic areas up to 
70% of the one-year-old children have malaria parasites in their blood (Roll Back 
Malaria Programme 2004). 
 11 
In an epidemiological survey in central Ghana in the year 2009, similar figures were 
found with a parasite prevalence of 64% and a maximum of seven malaria attacks 
per child per year in children below five years of age (Owusu-Agyei et al. 2009). 
  
Especially in areas of stable malaria transmission, acquired immunity is an important 
factor that prevents older children and adults from severe courses of malaria.  
Maternal antibodies usually protect neonates for the first six months of life, after 
which they become more susceptible to the parasite and develop more severe 
courses. Although the frequency of clinical malaria and the risk of death begin to 
decrease in children 2 to 5 years of age, full protection rarely occurs before the age 
of 5 years. In areas of uninterrupted high transmission, stable protection from severe 
disease is usually acquired from puberty onwards. Afterwards malaria episodes still 
occur, but less frequent and usually of mild character (Doolan et al. 2009). 
 
1.3 Clinical features of Malaria 
Clinical symptoms of patients with malaria are various and alternate depending on 
whether partial immunity is already achieved. Patients with transplacental developed 
protection or acquired partial immunity generally show only moderate physical 
impairment often initiated by a prodromal stage of tiredness and aching.  
Classical features for non-immune patients are an abrupt onset of an initial ‘cold 
stage’ with, sometimes heavy, rigors, a subsequent ‘hot stage’ with fever and a 
‘sweating stage’, when the patient’s temperature returns to physiological values. 
Those fever cycles are classically following a specific periodicity with asymptomatic 
periods, depending on the infecting Plasmodium species. 
In P. falciparum malaria, there is often no obvious periodicity perceptible, since fever 
may be continuous and accompanying symptoms like myalgia, headache and 
vomiting may be permanent. Plasmodium falciparum involves the threat of inducing 
severe courses of malaria particularly in young children and non-immune adults.  
Severe malaria is defined as the result of extensive multi-system involvement in  
P. falciparum malaria. Particularly in children, malarial infections tend to progress 
rapidly and death possibly occurs within hours. Neurological signs, like diffuse 
cerebral dysfunction with coma or convulsions may be signs of development of a 
cerebral malaria, which is one of the most important complications (Cook and Zumla  
2009c). 
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The majority of children who are brought to outpatient departments in life-threatening 
conditions, who die, die within the first 24 hours of admission (Marsh et al. 1995). 
This implies that proper diagnosis and early treatment is essential and life saving. 
In the past, several studies have been conducted to describe clinical features of 
major life-threatening conditions (e.g. malaria, sepsis, etc.). The findings should 
provide evidence-based data for clinicians to enable them to come to a treatment-
decision, even without laboratory or technical support (Dzeing-Ella et al. 2005, Marsh 
et al. 1995). The subjacent aim of this attempt was to objectify classification of 
severely ill children, which is yet widely subject to individual knowledge and 
experience of the treating physician. 
According to earlier studies, elevated body temperature or a report of fever, digestive 
disorders and convulsions represent some of the independent predictors for an 
infection with malaria (Bojang et al. 2000, Chandramohan et al. 2001, Muhe et al. 
1999). Researchers in Niger (Gay-Andrieu et al. 2005) could also show that 
neurological symptoms like coma or impaired consciousness were significantly more 
often presented by patients with malarial parasitaemia than by those children without 
parasites in their blood. Chandramohan et al. (Chandramohan et al. 2002) showed 
correlation of absence of cough, presence of pallor and a palpable spleen with a 
malaria infection. 
A study with Gabonese children depicted that hyperglycaemia and hyperlactataemia, 
occurring in 10% and 16% of the children respectively, were frequent laboratory 
features in patients with malaria (Dzeing-Ella et al. 2005).  
 
1.4 Diagnostic tools and treatment of malaria 
For decades microscopic detection of malaria parasites has been the gold-standard 
as diagnostic criterion for anti-malarial treatment as it still is (World Health 
Organization 2010b). But with the development of reliable alternatives such as rapid 
diagnostic tests (RDT’s), limitations of malaria parasite microscopy known already, 
got in the focus of discussion. Comparative studies revealed poor quality of 
microscopic examinations (Mukadi et al. 2011) particularly due to a lack of training of 
health staff (Bell et al. 2005, Bloland et al. 2003, Moerman et al. 2003) resulting in 
frequent overdiagnosis and overtreatment especially in lower level health facilities 
(Kahama-Maro et al. 2011). Especially in those settings RDT’s have been proven to 
be a reliable option beside microscopy (Moody 2002, Murray et al. 2003, Ochola et 
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al. 2006, World Health Organization 2003) for improving the management of febrile 
patients (Reyburn et al. 2007). Although RDT’s do not generally give reliable results 
in case of patients with very low parasite densities (≤200/l) (McMorrow et al. 2011), 
in high-transmission settings they can reduce prescription of anti-malarial drugs and 
prevent over-treatment (Ishengoma et al. 2011, Msellem et al. 2009). Also, they are 
effectively applicable by community health workers (Chanda et al. 2011, Mubi et al. 
2011). 
Development and distribution of RDT’s was focused by the WHO, as the 
recommendation for treatment with new Artemisine - combination therapies (ACT’s) 
led to expanding costs (Mutabingwa et al. 2005). Authorities were forced to seek for 
less complicated and cheaper methods than microscopy to detect focus groups that 
are to be treated with anti-malarials. In the year 2010 a total of 16 African countries 
were deploying RDT’s at the community level while the number of microscopic 
examinations fell about 10% from 2005 to 2009 (World Health Organization 2010b). 
Studies concerning the clinical implementation of RDTs showed that there are still 
clinicians who are not willing to consider parasite-test results for their treatment 
decision (Batwala et al. 2011, Lubell et al. 2008, Reyburn et al. 2007). Since 2010 
the WHO recommends presumptive treatment only for febrile children under five 
years of age living in high transmission areas. The organization therewith moved 
towards a parasite-based diagnosis in areas with medium and low transmission 
(World Health Organization 2010b), where decision-making was still based on 
subjective assessment of clinical signs and symptoms (Reyburn et al. 2007, Zurovac 
et al. 2006b). 
After evidence was growing that resistance to commonly used monotherapies, i.e. 
Chloroquine and Sulphadoxine-Pyrimethamine does not guarantee reliable success 
in treatment of P.falciparum malaria any longer, the switch to Artemisine-based 
combination therapies (ACT’s) was made in the early decade of 2000 (Bjorkman and 
Bhattarai 2005, Snow et al. 2005). By the end of 2009 all 42 african countries that 
were endemic for P. falciparum used ACT’s, whereby Arthemether – Lumefantrine 
(AL) accounted for the largest proportion of sold ACT’s followed by Artesunate – 
Amodiaquine (AA) (World Health Organization 2010b). Only sparse data is available 
concerning the question if the amount of distributed anti-malarials meets the needs of 
the patients, but it was however estimated that an average of 65% of treatment 
needs are fulfilled (World Health Organization 2010b).  
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Apart from standard treatment, ‘Intermittent Preventive Treatment in pregnancy’ 
(IPTp) provides pregnant women with a single dose of Sulfadoxine – Pyrimethamine 
(SP) at the beginning of the second trimester, followed by at least one dose no less 
than one month later (World Health Organization Technical Expert Group 2007). The 
effect of IPTp is described to depend on the susceptibility of the parasite to SP 
(Peters et al. 2007) and ideally comprises reduction of the prevalence of placental 
malaria, maternal anaemia and low birth weight (Kayentao et al. 2005, Peters et al. 
2007). However evidence of IPTp – failure also exists (Gies et al. 2008, Hommerich 
et al. 2007, Parise et al. 1998, Verhoeff et al. 1998) and is mainly attributed to 
accumulating resistance to SP (Harrington et al. 2011). In 2009, 33 of 43 endemic 
African countries have adopted IPTp - strategies (World Health Organization 2010b).  
Another preventive model targeting children under five years of age is the 
‘Intermittent Preventive Treatment for infants’ (IPTi) which involves provision of single 
dose Sulphadoxine – Pyrimethamine in parallel when they receive routine 
vaccinations for three times. Although not yet implemented in the WHO guidelines, 
research on IPTi – effectiveness delivered promising results (Aponte et al. 2009, 
Gosling et al. 2009, Grobusch et al. 2007, Manzi et al. 2008, Willey et al. 2011). 
 
1.5 Clinical algorithms for diagnosing malaria 
In the early nineties of the last millennium clinicians in malaria endemic countries 
were facing the situation of increasing death tolls due to malaria, while laboratory 
opportunities for confirmation of Plasmodium parasites were broadly lacking and 
medication was not yet widely enough distributed to cover all patients at need. 
With the first attempts of generating algorithms for clinical decision-making, 
researchers targeted the question, if it would be possible to distinguish on a clinical 
basis between children who are suffering from malarial parasitaemia and those who 
suffer from different conditions (Redd et al. 1996, Rougemont et al. 1991). To this 
point most children presenting to a health facility with fever or a history of fever were 
presumptively treated for malaria. This attempt, which is even recommended today 
by the WHO for some settings (World Health Organization 2010b), ensures a 
maximum of sensitivity to ensure capturing all parasitaemic children.  
In the following years researchers developed algorithms and case definitions in 
different settings and presented various results (Genton et al. 1994, Olivar et al. 
1991, Schellenberg et al. 1994). While a study from Zimbabwe could not find any 
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significant associations between certain symptoms and parasitaemia (Bassett et al. 
1991), others delivered a combination of symptoms that were able to increase the 
specificity of the diagnosis (Muhe et al. 1999). To compare the predictive value of an 
algorithm, performance of medical professionals using their clinical skills alone was 
set as a benchmark. In studies from Gambia and Tanzania pediatricians achieved 
this with a sensitivity of 86% and 99% and a specificity of 61% and 52%, respectively 
(Olaleye et al. 1998, Rooth and Bjorkman 1992). Researchers in Niger calculated a 
specificity for health worker diagnosis of 21% in the dry season and 0% in the wet 
season (Olivar et al. 1991). However, comparability of a study from the Sahel zone to 
those from Sub-Saharan Africa with stable transmission may be limited. 
In 1998, Olaleye et al. identified four symptoms (reduced feeding, sleepiness, 
shivering and cough absent) and five signs (feeling hot, palmar pallor, rash absent, 
cough not heard and increased respiratory rate) as promising predictors for malaria. 
After developing a score-based algorithm using a simple count of signs and 
symptoms present in the assessed child and by applying a cut-off of 6 or 8 symptoms 
respectively, a sensitivity of up to 90% and a specificity of over 60% was obtained for 
the diagnosis of malaria (Olaleye et al. 1998). Two years later, Bojang et al. used this 
algorithm for a prospective evaluation in Gambian children to test its validity and 
ease of use. Tested in a small population of 382 children, the application of this 
algorithm with an optimal cut-off score resulted in a sensitivity of 88% and a 
specificity of 62% for a diagnosis of malaria. For the same population sensitivity and 
specificity were obtained for a physician’s diagnosis without laboratory results, with 
82% and 61% respectively (Bojang et al. 2000). 
Rougemont et al. 1991 stated in their policy paper a case definition of a rectal 
temperature >37.7° C or splenomegaly or nailbed pallor would be able to increase 
specificity of the diagnosis to 41%, while sensitivity remains high with 85% 
(Rougemont et al. 1991). In a more recent study, conducted by Mwangi et al., a 
clinical algorithm containing 17 signs and symptoms was applied to children up to 15 
years of age. Among children under five years of age, the algorithm was able to 
select 84% of those patients with a parasitaemia ≥ 5000 parasites/µl of blood, but 
had a positive predictive value (PPV) of only 57%. In older children and adults the 
performance was even poorer (Mwangi et al. 2005). 
In 2002 Chandramohan et al. conducted a review of published studies about 
algorithms for diagnosing malaria. The authors evaluated both, combinations of only 
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two independent symptoms like fever and chills and/or sweating and score-based 
algorithms, which consist of up to ten signs and symptoms. Even so, they concluded 
that the accuracy of clinical algorithms is not sufficient enough to determine, whether 
antimalarial drugs should be given or withheld to children with febrile illness 
(Chandramohan et al. 2002). 
Algorithms should provide high accuracy for clinical decision-making, but signs and 
symptoms of uncomplicated malaria overlap with several other conditions. The best-
known algorithm for the clinical diagnosis of malaria is the Integrated Management of 
Childhood Illness (IMCI) - algorithm, which was introduced by the World Health 
Organization (WHO) in 1997 and which is still the leading guideline worldwide.  
 
1.6 Integrated Management of Childhood Illness 
In order to achieve the goals of reducing child mortality in children under five years of 
age the WHO launched its Integrated Management of Childhood Illness – program in 
1997 (Gove 1997). It should be built on the existing health facility structures, which 
were predominantly minted by minimal or non-existent diagnostic, laboratory and 
medical resources in primary health care settings. Assessment of children in health 
facilities in developmental countries did not follow any superior methodology and 
previous research was not implemented on an evidence basis.  
The three main components of the IMCI-strategy are: 
- Improving case management skills of health-care staff 
- Improving overall health systems 
- Improving family and community health practices 
Related to the community-level, these aims should result in a more accurate and 
reliable identification of childhood illnesses through higher qualified personnel and 
quicker referral of severely ill children to suitable health facilities. 
Implementation of appropriate care seeking behavior as well as preventive care in 
home settings and a more effective use of drugs were additional targets (Gove 
1997). 
The program was implemented in more than 75 countries worldwide (World Health 
Organization 2012c) and in 44 of 46 African countries by 2005 (World Health 
Organization 2012b). To ensure an optimal adaptation to the specific needs and 
capabilities of each environment, the WHO worked in close cooperation with local 
governments and ministries of health. 
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The IMCI - clinical guidelines are designed for use in poor clinical settings and 
represent one of the main parts of the initiative. The guidelines are described in the 
“IMCI-handbook” and cover algorithms for assessment of sick children in order to 
guide the health workers to the correct treatment. Apart from that the guidelines 
provide structured information about disease prevention, e.g. vaccination or bed net-
use as well as nutritional counseling (World Health Organization 2010d). 
After individual national adaptations of the handbook’s content, it was made available 
to teaching institutions to incorporate the guidelines in the education of doctors, 
nurses and other health professionals (World Health Organization 2010c, World 
Health Organization and Ghana Office 2004). 
Ghana started IMCI in 1998 in four pilot districts after initial capacity building. During 
the year 2000 all districts had started and - according to latest available data - there 
are currently 33 districts working with IMCI (World Health Organization et al. 2004). 
Since the beginning of implementation there is an ongoing, partly well–documented, 
review process to evaluate efficiency and practicability of IMCI and development of 
mortality-rates. Several studies showed a major improvement of health workers 
performance in facilities, where the staff was previously trained in IMCI case 
management. Children assessed by those health workers received a more 
appropriate treatment and caretakers were more likely to receive correct instructions 
about how to continue treatment at home and when to return to the health facility 
compared to children, who were assessed by “non-IMCI health workers” (Armstrong 
Schellenberg et al. 2004, El Arifeen et al. 2004).  
As implementation of IMCI was adopted on a regional basis one of the consequential 
postulations was to begin all new child survival efforts with local epidemiology, 
targeting the major causes of death within each region and even down to the district 
level (Bryce and Victora 2005). 
 
1.7 Health care setting in Ghana and West Africa 
Although Ghana is one of the higher developed countries in West Africa, the health-
system is far away from providing sufficient health care to every child. In 2008, 30% 
of all children under five years of age were stunted and especially the “under-five-
survival” in rural regions was still less likely, since 75 children per 1000 live births 
died in urban regions in 2008 compared to 91 deaths per 1000 live births in rural 
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areas. The physician density for the entire country of Ghana was only 0.85 per 
10.000 people in 2009(World Health Organization 2009).  
In contrast to the partially low utilization of health facilities in some other areas, the 
Ashanti region, where this study took place, is relatively well equipped with overall 
530 hospitals and health stations. The majority (53%) is privately managed and 
almost a third is operated by the governmental Ghana Health Service (Ghana Health 
Service 2008). 
Despite the general deficits, Ghana is also one of the countries that outperformed the 
average figures of the ‘WHO African Region’. For instance, 78% of women received 
‘antenatal care (4+ visits)’ in the year 2008 (vs. an average of 44% of women in the 
entire WHO African region). For the criterion ‘births attended by skilled health 
personnel’ it was 59% (vs. 48%) and for ‘measles immunization’ it was 93% (vs. 
69%) (World Health Organization 2009). 
However, there are other reasons existing that keep the overall health situation on a 
low level: The three main reasons are namely financial barriers, insufficient health 
care–seeking behavior and traditional beliefs. Financial barriers particularly comprise 
transport costs to the health facilities, costs for medication and the health service 
itself since memberships in community-based health insurance schemes (CBHI) are 
frequently not existing (Boateng et al. 2008, Sarpong et al. 2010, Smith et al. 2008). 
In Ghana 46.8% of the total expenditure on health had to be paid by the patients 
(data from 2009) (World Health Organization 2010b). Improvement of health care – 
seeking behavior, which is also one of the main goals of the IMCI – strategy, has 
proven to be a complex problem. In 2008 for instance, only 51% of children in Ghana 
who showed symptoms of an acute respiratory infection were taken to a health 
facility (World Health Organization 2010b). 
Other studies highlighted that mothers purchased drugs for their children without 
seeking prior medical help (Mbagaya et al. 2005) or presented them to health 
facilities later than 24 hours after onset of febrile illness in high transmission areas 
(Deressa et al. 2007). Those inhibitions for seeking medical assistance are often 
associated with traditional beliefs and trust in traditional healers.The belief of an 
illness not being treatable by modern medicine may also lead to a lack of recognition 
of danger signs (Hill et al. 2003). In many countries malaria has different synonyms in 
each community and is known as a local disease, which is often attributed to evil 
spirits. Thus, convictions still widely exist that such an illness is only curable by 
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attending traditional healers (Makundi et al. 2006). Data from 500 interviewed 
patients with malaria in Ghana showed, that 43% of them had taken anti-malarials 
prior to hospital attendance: 77% of those had used the drugs inappropriately 
(Buabeng et al. 2007). 
 
1.8 Aim of the study 
The goal of the present study was to generate and evaluate an age-derived clinical 
algorithm using simple clinical signs and symptoms for the diagnosis of P. falciparum 
parasitaemia. An algorithm such like this could idealley help to detect a focus group 
of children for presumptive treatment if resources are scarce. To date there is no 
data on age-derived clinical algorithms available. For better adoption to the clinical 



















2. Population and Methods 
 
2.1 Study Area 
Ghana is located on the Gulf of Guinea in West Africa and consists of a total area of 
238.537 km2 with an estimated population of 20.5 millions. More than 100 different 
ethnicities live in the country, the Akan (e.g. Ashanti, Fanti, Akim) account for the 
majority. The present study took place in Agogo, which is located in the Ashanti Akim 
North District, 80 kilometers east of the regional capital Kumasi (Unicef 2007).  
The population in the Agogo District and the neighbored Ashanti Akim North District 
is estimated with 140.000. Most people generate their income with small agriculture 
business or as retailers. Cultivation comprises Maize, Cassava, Plantain, Cocoyam 
and Yam.  
Situated in a valley, Agogo is surrounded by secondary forested tropical uplands, 
which are interspersed with discontinuous farmland. With a fully developed road, 
Agogo is well connected to the bigger city of Konongo in the southwest. All other 
villages around Agogo are only reachable via dirtroads, which can be temporarily 
flooded during the rainy months.  
The climate is tropical, with a median-temperature of 27°C and a humidity averaging 
about 85%. The average yearly precipitation is about 166.7 cm (Ghana Health 
Service 2008). 
Plasmodium falciparum is the predominant malaria parasite species followed by 
Plasmodium malariae in the savanna and Plasmodium ovale in rainforest regions 
and vectors are Anopheles gambiae and Anopheles funestus(Browne et al. 2000). 
Transmission of malaria parasites in the Ashanti region is stable, with an estimated 
entomological inoculation rate of >400 per year (Kobbe et al. 2007). 
In the entire Ashanti region 530 health-facilities were counted. Thirty-two percent of 
them are operated by the governmental Ghana Healths Service (GHS). With 38%, 
Kumasi has the highest percentage of facilities (Ghana Health Service 2008). 
The Agogo Presbyterian Hospital (APH) is situated at one of the main roads, close to 
stops of mini busses and taxis. The hospital provides 250 beds in five departments 
(Surgery, Internal Medicine, Gynaecology and Obstetrics, Pediatrics and 
Ophthalmology) and employs 19 physicians. Besides, the hospital maintains 
outstanding certified laboratory facilities (Agogo Prebyterian Hospital 2010). The 
pediatric department is divided into the Child Welfare Clinic (Outpatient Department), 
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a neonatal intensive care unit (nursery) and the children’s ward as well as a 
maternity. 
The Outpatient department offers health care to children from birth up to 15 years of 
age and is equipped with simple devices such as weighing scales, stadiometer, 
thermometers, consulting tables and two examination couches. It is operated by a 
team of two pediatricians and five nurses as well as two health workers. 
 
2.2 Data collection 
2.2.1 Study period 
All children aged up to 15 years, who were presented to the outpatient department by 
their parents or caretakers in the period between May 2007 and July 2009 were 
included in the study. 
 
2.2.2 Inclusion and exclusion criteria 
All children in the age of 15 years or below who were attending the OPD for any kind 
of illness were initially eligible for inclusion in the study. The legal guardian of the 
child had to sign the informed consent after in-depth explanation of the purpose of 
the study.  
In case of withdrawal of the legal guardian to sign the informed consent or to provide 
blood samples for examination, the patient was excluded from the study population. 
 
2.2.3 Recruitment of patients in the Outpatient department 
In the present study individuals could be included for multiple times. Upon 
registration in the OPD the study nurse had to decide whether the individual had to 
be defined as a new patient or a review. For the analysis of this study a “patient” was 
defined as an individual visiting the OPD. To be classified as a new patient (i.e. “an 
individual with a new episode of illness”) the individual had to attend the OPD without 
any prior visit within the last 14 days. Individuals who had already taken part in the 
study and who attended the OPD for the second time within 14 days were handled as 
a review and were not included in further analyses. Below, the term ‘patient’ will be 
used for the single visit of one individual according to this definition. 
Each patient below 15 years of age who presented to the OPD within the study 
period, was registered in the ward book by a study nurse on duty at the registration 
counter. Afterwards, body temperature, weight and height were measured and 
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vaccine immunization state was documented. After a member of the study team has 
ensured, that the patient was not already registered as a participant of the study, the 
parents or guardians were asked for consent of enrolling the child in the study. If they 
agreed they had to sign the informed consent form (ICF). If the parents or legal 
guardians of the child were illiterate, they were asked to provide a thumbprint. ICFs 
of parents or legal guardians who were illiterate had to be signed by a witness too. 
Afterwards a case report form (CRF) and a lab sheet were prepared and the patients 
were forwarded to an experienced pediatrician, who conducted a detailed interview 
with the child and/or parents and performed a physical examination. All findings and 
the diagnosis were entered in the CRF. 
Each patient was asked to provide an EDTA-blood sample for a blood count and a 
sample for a malaria slide. After both of these results were available, the patient 
returned to the pediatrician, who decided, whether the patient had to be referred to 
the ward or could be sent home after treatment. 
 
2.2.4 Case Report Form (CRF) 
The case report form (CRF) is a three page–document that had to be filled out for 
each patient. 
The personal data on the front page, as well as state of vaccine immunization, 
weight, height and body temperature on admission, were entered by the study nurse 
on duty at the registration counter.  
The CRF was designed in two rows, of which one had to be filled out by the admitting 
study nurse at the registration and the second had to be completed by a doctor. 
Where the nurse mostly had to choose between binary options (e.g. “yes” or “no”, 
“productive cough” or “dry cough”), the doctor had more space for individual 
comments and qualitative assessment. Since laboratory results were only available 
after a while, all signs and symptoms (e.g. palmar pallor) were assessed subjectively. 
On the second half of the last page the pediatrician had to state a final diagnosis, 
which should be confirmed by laboratory findings. Further it was necessary to note 






2.2.5 Laboratory Request Form 
The laboratory request form was also prepared for each patient, who was enrolled in 
the study. The doctor who assessed the child in the outpatient department had to 
choose, which tests are needed to confirm the suspected diagnosis. Together with 
the blood samples the laboratory request form was then forwarded to the laboratory, 
where all results of the analyses were written down on the form. Except of special 
analyses for clinical chemistry, which were sent to the Komfo Anokye Teaching 
Hospital Kumasi, all common examinations were performed in the hospital’s 
laboratory and results were at latest available within a few hours. 
 
2.2.6 Data Management 
For each individual a study folder was created, which contained all CRFs, laboratory 
request forms and other patient related documents. The folder remained in the OPD, 
until it was completed and a diagnosis was made. Afterwards, the folder was 
forwarded to the data entry clerks, who double-entered the data within 48 hours. For 
data entry, the software “4th Dimension” was used. Inconsistencies and needs of 
clarifications were managed by the data manager, who was also responsible for 
cross–checking the data. Once in a month data synchronization with the Bernhard-
Nocht-Institute of Tropical Medicine (BNITM) in Hamburg was performed. A list with 
inconsistencies was sent back to Agogo to be corrected in the database by the data 
entry clerks. At all other times the folders were stored in a locked room with access 
for study personnel only.  
 
2.2.7 Consent and Ethical Approval 
The study was conducted in accordance with the ethical principles of the Declaration 
of Helsinki, and consistent with Good Clinical Practice (GCP) and the applicable 
regulatory requirements. Ethical approval for the study was obtained from the 
respective responsible Ethics committees, namely from the School of Medical 
Science, Kwame Nkrumah University of Science and Technology(KNUST), Kumasi. 
Mothers of children were informed about the aim of the study in presence of a 
witness and their understanding was assessed by a set of standard questions 




2.2.8 Data Management and Analysis Software 
Data Entry and Evaluation was performed using 4th Dimension Data Management 
software (4D SAS, France). Data analyses were carried out by using STATA IC/10.0 
Statistical and Data Analysis Software (Stata Cooperation, California). 
 
2.3 Methodology of laboratory examinations 
2.3.1 Blood count 
For analysis of the capillary blood samples, a Sysmex KX-21N Haematological 
Analyzer (Sysmex Corporation, Kobe, Japan) was used. The machine was tested 
and calibrated on a daily basis. A three level control (Eightcheck-3WP controls (Low, 
Normal and High)) was run each morning to ensure the function of the machine. 
The counter was able to provide a full blood count as well as differentiation of white 
blood cells within a few minutes.  
 
2.3.2 Malaria slide 
For detection of malaria parasites, a thin and a thick blood film were prepared for 
each child enrolled in the study. Therefore capillary blood was collected out of the 
fingertip after alcoholic skin disinfection. To avoid dilution, the first three drops of 
blood were discarded.  
For preparation of the blood slide a single drop of blood was placed on a object slide 
and was then greased out with the help of a second object slide, held in an angle of 
30° to 45°. For the thick blood film three drops of blood were collected on the object 
slide and mingled instantly to form a thick layer of blood. 
Both slides were fixed in pure methyl alcohol, after they were dried. After renewed 
drying, the slides were stained in Giemsa Solution (10%) with a pH between 7.0 and 
7.2 for 10 to 15 minutes. Afterwards they were rinsed with clear water and put in a 
vertical position for drying. 
For counting the parasites, the lab technician used Immersion oil microscopy with 
100x magnification. After seeking for a visual field showing eight leukocytes in the 
thick blood film, parasites were counted simultaneously to the leucocytes, until 200 
leucocytes were counted. According to the current blood count, parasites were 
calculated up to 1l of blood. 
If there was no blood count available, an average of 8000 leucocytes per l of blood 
was estimated (Greenwood and Armstrong 1991). If there were no parasites visible 
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after counting of leucocytes, the slide was decided to be negative. In cases of very 
high parasite densities, the parasite count was performed with the thin blood film, 
which was made out of a single drop and parasite densities were counted up to 1000 
erythrocytes. 
 
2.4 Study population and processing of database for analysis 
2.4.1 Preparation of datasets for analysis 
During the study period between May 2007 and July 2009, 4981 individuals between 
two months and five years of age were included in the study population. As many of 





















Figure 1.  Enrollment and exclusion of patients aged 2 months to five years 
a A patient was defined as an individual visiting the OPD. b Case report forms must have  
  information for each variable in Table 1 available. 
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All visits of children who were younger than two months or older than sixty months at 
the time of their visit were not included in the analysis. Consequently, it was possible 
that one individual had three visits during the study period, but was included only 
once because of exceeding the age limit of five years after his/her first visit. 
A set of variables was compiled which had to be available for each patient to ensure 
comparability and consistency. Patients who had missing values for one of the 
variables in Table 1 were excluded from the analysis. Patients for who no malaria 
count – result was available were also excluded.  
After exclusion of all patients with incomplete datasets, 5447 patients (3641 
individuals) were left (Figure 1). 
 
2.4.2 Preparation of variables 
Initially, values for more than 150 different variables were transferred from the CRF 
into the database. First analyses revealed that for several of these variables no 
values were available. To ensure high consistency throughout the dataset it was 
necessary to consider only those variables that have been assessed in all patients. 
Therefore it was evaluated which variables could be excluded without reducing the 
total number of patients in the analysis by more than 10%. 
This attempt should prevent loosing disproportional numbers of cases, only to have a 
single variable available for each case that is potentially not important for the 
analysis. 
Some of the variables were direct translations of questions (e.g. “cough: yes/no”), 
others were completely new generated out of text-statements (e.g. “child is poorly 
feeding”). Finally all variables used for analysis were binary information. 
 
2.4.3 Data analysis 
After description of the distribution of sex, age, personal data, parasitaemia and signs 
and symptoms, each variable from Table 1 was put in a bivariate regression analysis 
to compute Odds Ratios between symptoms and P. falciparum parasitaemia (Table 
2). The resulting Odds Ratios were used to decide whether the variables were 





Table 1. Variables for which values were required for inclusion  
Variablea Short definition 
  
Nutrition changed to 
poor feeding 
Reduced eating or breastfeeding during the last 5 days 
Convulsions Report of convulsions 
Elevated body 
temperature 
Measured axillary body temperature of 37.5°C or above 
Report of fever History of fever within the last five days 
Prostration Abrupt failure of function or complete physical exhaustion 
Cardiac fatigue Any signs of cardiac fatique (e.g. pretibial oedema or dyspnoea) 
Cyanosis Any signs of cyanosis (e.g. on the lips or nailbeds) 
Skin rash Any visible rash on the skin 
Skin depigmentation Any visible depigmentation of the skin 
Skin abnormalities / 
Other skin problem 
Any skin abnormalities that are not rash or depigmentation 
Palmar pallor Pallor of the palm (e.g. in comparison to the hand of the physician) 
Jaundice Any visible jaundice of the sclera or the skin 
Cough History or presence of cough 
Breathing difficulties Stressed and/or impaired breathing, inability to breath deeply 
Breathing fast Increased breathing frequency (2-12 months of age: ≥50 breaths/min, 12 
months – 15 years: ≥40 breaths/min) 
Deep breathing Increased deepness of breathing (e.g. as compensation of metabolic 
acidosis) 
Respiratory distress Severe respiratory impairment 
Chestindrawing Visible indrawing of the chest wall in inspiration (syn. subcostal indrawing) 
Running nose History or presence of running nose 
Blocked nose History or presence of blocked nose 
Diarrhoea Loose stools with a frequency 
Vomiting History or presence of vomiting 
Drinking thirsty Increased sensation of thirst and increased quantity of drunken fluid 
Pinch abdomen present Reduced skin turgor (e.g. in case of dehydration) 
Earpain History or presence of earpain 
Malnourishment Subjective impression of malnourishment 
 
a
Variables were binary coded (0;1), patients included in the analyses must have a value  





Those variables providing both, an Odds Ratio ≤0.83 or ≥1.20 and an occurrence in 
at least 1% of cases with present parasitaemia were put in a forward and a backward 
stepwise logistic regression. For variables with an Odds Ratio of ≤0.83 bunched 
inverse variables were generated (e.g. no respiratory symptoms). To be positive for 
this inverse variable a patient must not present a symptom of the respective group of 
symptoms (e.g. for no respiratory symptoms: no chestindrawing, no breathing 
difficulties, no fast breathing, no running nose, no blocked nose and no cough). 
 
2.4.4 Stepwise logistic regression 
Variables, which met the criteria regarding a potential predictive value, were first 
entered into a forward stepwise logistic regression to determine the minimum number 
of independent variables necessary to accurately estimate the outcome.  
The outcome was defined as Plasmodium falciparum parasitaemia of any density, 
detected by either thin or thick blood film.  
The model selected the variable strongest related to the outcome and entered it into 
the model first. Following variables were selected according to the best improvement 
to the fit of the model after adjustment to all other variables. 
At a certain point, where none of the remaining independent variables improved the 
fit of the model significantly, entering of new variables was stopped. For statistical 
discrimination a p-value of 0.05 was set as cutoff. 
Backward stepwise regression proceeded inversely and entered all independent 
variables first. Due to the better ability of backward logistic regression models in 
determining suppresser effects and the need of testing the robustness of the model, 
it was also performed with all independent variables (Lemeshow S and Hosmer DW 
jr. 2000). 
Variables that were estimated as being predictive by both parameter reduction 
methods were then entered in the CART – analysis.  
 
2.4.5 Classification and regression tree analysis (CART) 
CART-Analysis, also known as ‘Recursive Partioning’, is a technique for separating 
the independent variables, i.e. the occurrence of a certain sign or symptom, into 
subgroups based on the outcome.  
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Using the Martingale Residuals of a Cox regression model to calculate approximate 
chi-square values for all possible cut-points on all of the CART covariates, this 
method results in calculation of individual relative hazard rates. 
Beginning with a parent node containing all cases of a specific age group, CART is 
continuously trying to maximize the purity, i.e. to segregate children who are affected 
by parasitaemia from those children who are not affected. Therefore, the model 
generates a decision tree by splitting the cases of the parent node at an optimal split 
point where the arising child nodes provide greater purity (better segregation of 
affected and non-affected children). For detection of the optimal split point the 
entered binary prediction variables were used. 
Every child node in turn can become a parent node, as CART continues the splitting 
process until statistical analysis indicates that another child node would not be of 
greater purity (Marshall 2000, Speybroeck 2011). The resulting tree is structured as a 
sequence of yes/no questions. For calculation of cut-points a p-value of <0.05 and a 
minimum size of the subgroup of 10 cases were set.  
The target dimension of a Cox regression is the time until occurrence of a certain 
event, i.e. death or illness. The effect of the analyzed explanatory variable during this 
time is described as Hazard Ratio. CART therefore requires the input of a certain 
time variable. In this study all enrolled children had already reached the stage of 
experiencing the outcome, in the sense of being positive or negative for 
parasitaemia. As all signs or symptoms, which were described by the pediatrician, 
were assessed at the same time and no follow-up assessment was conducted, time 
was treated as a dummy variable, being ‘1’ for any assessed symptom. 
By using this attempt, the influence of the time variable was disconnected from the 
CART model. CART then simply worked as a method of describing the strength of 
association or non-independence between two binary data values, by calculation of 
the expected number of events for each subject within a subgroup.  
Concerning this variation, the regular output of a Hazard Ratio can be regarded as 
Odds Ratio as well (Speybroeck 2011). 
CART - analysis was performed separately for children aging 2 – 12 months and for 





2.4.6 Classification of models 
Sensitivity, specificity, negative (NPV) and positive predictive values (PPV) were 
calculated for each CART model and for the Integrated Management of Childhood 
Illness – algorithm. Single signs and symptoms, as well as combinations of those, 
were also classified. 
 
2.4.7 Testing null hypotheses 
For testing the null hypothesis on the significance of different haemoglobin (Hb) 
concentrations in patients with palmar pallor an unpaired two-sample t-test was 
performed, assuming a Student’s t distribution. 
 
2.5 Clinical definitions 
2.5.1 Report of fever 
A report of fever was defined as any history of fever or ‘feeling hot’ within five days 
prior to the visit reported by the legal guardian of the child. Because households in 
the Ashanti region lack in thermometers, most of the febrile episodes could not be 
confirmed with thermometers at home.   
 
2.5.2 Elevated body temperature 
An elevated body temperature was defined as a body temperature of 37.5° Celsius or 
above (≥ 37.5°C). The temperature elevation was always measured with a 
thermometer by one of the study nurses upon assessment of the patient. 
 
2.5.3 IMCI definitions 
The World Health Organization (WHO) recommends classification of febrile children 
based on the malaria risk of the area. In high malaria risk areas like Ghana where 
more than 5% of fever cases are due to malaria, two IMCI classifications are 
applicable: 
 
-Very severe febrile disease 
  Children who suffer from a very severe febrile disease according to the WHO 
  guidelines, have to show any of the general danger signs (unability to drink 
  or breastfeed, vomiting everything, convulsions, unconsciousness or 
  lethargy) or a stiff neck. 
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- Malaria 
   If a child has a fever (by history, feeling hot, or a temperature of 37.5°C and  
    above), but no general danger sign, then a child is classified as a case of  
malaria. Parasitological laboratory diagnostics are not required for this 
definition. 
 
2.5.4 Age groups 
For the CART analysis the study population was stratified in two age groups. 
 - Age group 1: Children between ≥2 and <12 months of age 
 - Age group 2: Children between ≥12 and <60 months of age 
 
Instead of writing ”between ≥2 and <12 months” or “≥36 - <48 months” in some 
figures and tables it was just written “between 2 and 12 months” or “36 – 48 months” 


















3.1 Describing the population 
During the study period 5447 patients were enrolled for whom all required data for 
analysis was available. Beginning in May 2007 the number of monthly study 
recruitments rose up to a maximum of 450 in the month of April 2008. During the last 
8 months of recruitment until July 2009 the OPD was not well staffed with personnel 
and only smaller numbers of cases were registered. Apart from this no significant 



















Figure 2. Enrollment of 5447 patients during the study period between May 2007 and  
                July 2009 
 
 
For the present study a patient was defined as an individual visiting the OPD, 
whereby it was possible for an individual to be included for multiple times according 
to the inclusion criteria. Thus single and multiple visits of 3641 individuals result in a 
total of 5447 patients in the analyses. As Figure 3 demonstrates 2516 (69.1%) of all 
registered individuals visited the OPD only once. Six-hundred-ninety-seven (19.1%) 
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Figure 3.  Distribution of single and multiple visits of 3641 individuals  
 
 
Table 2 shows that sex was almost equally distributed among the registered children  
with 2882 (52.9%) male patients and 2565 (47.1%) female patients. Grouped into two 
age groups (2-12 months and 12-60 months), the fraction of children aged between 2 
and 12 months was smaller with 1304 enrolled patients compared to 4143 patients 
between 12 and 60 months, respectively.  
According to their parents or guardians the majority of children belonged to the ethnic 
group of Akan (84.5% of patients 2-12 months of age and 82.6% of patients 12-60 
months of age). This group was followed by the ethnicities Northeners (10.4% vs. 
12.3%), Ewe (2.1% vs. 2.4% ), Ga (0.8% vs. 0.9%) and Others (2.2% vs. 1.8%). 
Regarding patients in all ages over 53% (2921) of the patients came from outside of 




Table 2. Distribution of sex, age, ethnicity and origin among the study population 
 Patients 2-12 months Patients 12-60 months* Total 
 (n=1304) (n=4143) (n=5447) 
Sex    
Male 713 (54.7%) 2169 (52.4%) 2882 (52.9%) 
Female 591 (45.3%) 1974 (47.7%) 2565 (47.1%) 
    
Ethnicity    
Akan 1102 (84.5%) 3420 (82.6%) 4522 (83.0%) 
Ewe 27 (2.1%) 98 (2.4%) 125 (2.3%) 
Ga 11 (0.8%) 39 (0.9%) 50 (0.9%) 
Northeners 136 (10.4%) 510 (12.3%) 646 (11.9%) 
Others 28 (2.2%) 75 (1.8%) 104 (1.9%) 
    
Residence    
Agogo 524 (40.2%) 2002 (48.3%) 2526 (46.4%) 
Outside Agogo 780 (59.8%) 2141 (51.7%) 2921 (53.6%) 
    
* One patient had missing information for “ethnicity”  
 
 
3.2 P. falciparum parasitaemia, fever and ‘clinical malaria’ 
Disregarding the clinical presentation or any suspected diagnosis every patient was 
asked to provide a blood sample for preparation of a thin or thick blood film. 
The prevalence of P. falciparum parasitaemia was 13.8% in children aged 2-12 
months and 30.6% in children between 12 and 60 months of age, which resulted in 
an overall prevalence of parasitaemia of 26.6% regarding the full age range (Table 
3). 
In Figure 4 and Figure 5, the distributions of P. falciparum parasitaemia and ‘clinical 
malaria’ are visualized. Both of the prevalences were increasing up to the age of 36 
months, with a peak prevalence of 38.5% for P. falciparum parasitaemia and 36.0% 
for ‘clinical malaria’, respectively for the children aged between three and four years. 
The youngest children aged between 2 and 12 months were least affected with 
prevalences of 13.8% for parasitaemia and 12.1% for ‘clinical malaria’ respectively. 
As almost all children with a parasitaemia, had an elevated body temperature or a 

























Figure 4. Age distribution of P. falciparum parasitaemia in 5447 patients 
 
Body temperature was measured for each child enrolled in the study and the legal 
guardian was additionally asked for presence of fever within the last five days. 
Irrespective of the age, the percentage of children with an elevated body temperature 
on admission was significantly higher with 882 (60.9%) patients in the group of 
patients with detected parasitaemia, compared to 1134 (28.6%) children with a body 
temperature equaling to 37.5°C or above and a negative malaria film (Table 4). 
If only a report of fever was considered as a criterion for having fever, in general 
more of the admitted patients were found to have experienced an episode of fever 
with a total number of 1401 (96.7%) patients with positive malaria films and 3167 

























Figure 5. Distribution of diagnosis ‘clinical malaria’ in patients of different age 
 
 
The vast majority of children (83.0%) has received one or more doses of anti-pyretics 
(e.g. Paracetamol) before attending the outpatient department. Nevertheless, most of 
the admitted children with a positive blood film had an elevated body temperature. 
Among children with a negative malaria slide, only 1143 (28.6%) had a persisting 
elevated temperature. Comparing the different age groups among children with 
positive parasite state, it is obvious that the role of fever increases slightly with the 











Patients 2-12 months 
(n=1304) 
 Patients 12-60 months 
(n=4143) 
 All patients 
(n=5447) 
No Yes  No Yes  No Yes 
1124 (86.2%) 180 (13.8%)  2874 (69.4%) 1269 (30.6%)  3998 (73.4%) 1449 (26.6%) 
a 




Table 4: Application of different definitions of fever on patients with and without P. falciparum parastiaemia 








 No Yes  No Yes  No Yes 
 (n=1124) (n=180)  (n=2874) (n=1269)  (n=3998)  (n=1449) 
Elevated body 
temperature ( 37.5°) 
354 (31.5%) 102 (56.7%)  789 (27.5%) 780 (61.5%)  1143 (28.6%) 882 (60.9%) 
Report of fever 
b
 857 (76.3%) 172 (95.6%)  2310 (80.4%) 1229 (96.8%)  3167 (79.2%) 1401 (96.7%) 
Paracetamol taken 782 (69.6%) 162 (90.0%)  2004 (69.7%) 1040 (82.0%)  2786 (69.7%) 1202 (83.0%) 
a 
P. falciparum parasitaemia of any density was detected by thin or thick blood film 
b
A report of fever was defined as any history of fever within the last five days
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3.3 Distribution of clinical diagnoses and signs and symptoms 
After completing the examination of each child, the pediatrician had to state a clinical 
diagnosis. In Table 5 all clinical diagnoses are sorted by frequency for each age 
group. In both groups “malaria” accounts for the first or second most frequent 
diagnosis, as 2264 (54.6%) children aged 12-60 months and 494 (37.9%) children 
aged 2-12 months were diagnosed with malaria. Regarding the whole study 
population 50.6% (2758) of patients were diagnosed with malaria. 
The second most common diagnosis (beyond the youngest children it was even the 
most frequent) was an upper respiratory tract infection (“URTI”).  
 “Otitis media” and “Gastroenteritis” are two other diagnoses that rank beyond the 
“top five” diagnoses in both age groups. “Otitis media” was almost equally distributed 
in children 12-60 months of age (11.9%) and in children between 2 and 12 months of 
age (11.4%).  “Gastroenteritis” was diagnosed in every fifth child (19.3%) of the 
youngest children (2-12 months of age) and in 11.6% of children between 12 and 60 
months of age. “Anaemia” was diagnosed in different graduations of severity, 
commonly according to the clinical presentation of the patient. 
In both age groups “moderate anaemia” was the most frequent form of anaemia with 
2.6% in children 2-12 months of age and 3.4% in children aged 12-60 months. 
 
For each patient a detailed case report form with all clinical signs and symptoms was 
completed. In Table 6.1 and 6.2, all signs and symptoms (variables) are listed in 
three categories. The first category lists the variables, which were assessed by the 
physician or nurse, the second gives information about variables, which were taken 
from the history of the child. The third category informs about variables, which were 
generated during the analyses. 
Sorted by frequency and irrespective of the generated variables, the most common 
symptoms in patients without parasitaemia are a report of fever in 2647 (66.2% of all 
patients without parasites) children, nutrition change to poor feeding in 2617 (65.5%) 
patients, cough in 2500 (62.5%) patients, running nose in 2466 (61.7%) children and 





Table 5. Distribution of clinical diagnoses 
Diagnosis* Patients  Diagnosis* Patients 
months 
 Diagnosis* Patients 
 2–12 months   12-60 months   2-60 months 
  n=1304 (%)    n=4143 (%)    n=5447 (%) 
        
URTI a 604 (46.3)  Malaria 2264 (54.6)  Malaria 2758 (50.6) 
Malaria 494 (37.9)  URTI a 1642 (39.6)  URTI a 2246 (41.2) 
Gastroenteritis 252 (19.3)  Otitis media 491 (11.9)  Gastroenteritis 731 (13.4) 
Otitis media 149 (11.4)  Gastroenteritis 479 (11.6)  Otitis media 640 (11.7) 
Bronchopneumonia 88 (6.7)  RTI c 172 (4.2)  Bronchopneumonia 245 (4.5) 
UTI b 54 (4.1)  Bronchopneumonia 157 (3.8)  RTI c 224 (4.1) 
RTI c 52 (4.0)  Moderate Anaemia 139 (3.4)  UTI b 185 (3.4) 
Malnutrition 36 (2.8)  UTI b 131 (3.2)  Moderate Anemia 174 (3.2) 
Moderate Anemia 34 (2.6)  Malnutrition 90 (2.2)  Malnutrition 126 (2.3) 
Impetigo 30 (2.3)  Tinea capitis 75 (1.8)  Enteritis 79 (1.5) 
Enteritis 24 (1.8)  Tonsillitis 58 (1.4)  Tinea capitis 76 (1.4) 
Severe anemia 20 (1.5)  Enteritis 55 (1.3)  Severe anemia 73 (1.3) 
Dysentery 16 (1.2)  Severe Anaemia 53 (1.3)  Dysentery 69 (1.3) 
Conjunctivitis 14 (1.1)  Dysentery 53 (1.3)  Tonsillitis 58 (1.1) 
Sepsis 14 (1.1)  Helminthiasis 47 (1.1)  Conjunctivitis 53 (1.0) 
Pneumonia 9 (0.7)  Anaemia 40 (1.0)  Helminthiasis 49 (0.9) 
Giardiasis 8 (0.6)  Conjunctivitis 39 (0.9)  Impetigo 48 (0.9) 
Anemia 7 (0.5)  Pneumonia 36 (0.9)  Anemia 47 (0.9) 
Septic skin lesion 4 (0.3)  Septic skin lesion 36 (0.9)  Pneumonia 45 (0.8) 
Lobarpneumonia 3 (0.2)  Sepsis 30 (0.7)  Sepsis 44 (0.8) 
Helminthiasis 2 (0.2)  Lobarpneumonia 28 (0.7)  Septic skin lesion 40 (0.7) 
Tinea capitis 1 (0.1)  Giardiasis 23 (0.6)  Giardiasis 31 (0.6) 
Tonsillitis 0 (0.0)  Impetigo 18 (0.4)  Lobarpneumonia 31 (0.6) 
Enteric fever 0 (0.0)  Enteric fever 12 (0.3)  Enteric fever 12 (0.2) 
 
       * Patients could have multiple diagnoses 
            aURTI = Upper Respiratory Tract Infection, bUTI = Urinary Tract Infection, cRTI = Respiratory Tract Infection
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For those children who had parasites in their blood, the most predominant symptoms 
were a report of fever in 1212 patients (83.6% of all children with parasites), nutrition 
change to poor feeding in 1042 (71.9%), an elevated body temperature in 882 
(60.9%) children, running nose in 608 (42.0%) children and vomiting in 595 (41.1%) 
of the children.  
Considering a difference in the frequency of presenting the variable of at least five 
percent, some variables were more often presented in patients with parasitaemia 
than in those patients without parasites: Palmar pallor (17.9 % in parasitic patients 
versus 5.5% in non – parasitic patients), report of fever (83.6 % vs. 66.2%), nutrition 
change to poor feeding (71.9% vs. 65.5%) and vomiting (41.1 % vs. 31.9%). 
Patients without detected parasites in their blood more often showed a running nose 
(61.7% in non-parasitic patients versus 42.0% in parasitic patients), skin rash (13.3% 
vs. 6.3%), cough (62.5% vs. 40.1%) and diarrhoea (31.6% vs. 25.7%). Signs of 
severe illness like prostration, cyanosis, convulsions and respiratory distress were 
not frequently assessed in the OPD. 
Each variable from Table 6.1-2 was put in a bivariate regression analysis to compute 
Odds Ratios between symptoms and P. falciparum parasitaemia. The resulting Odds 
Ratios were used to decide whether the variables were handled as ‘potentially 
predictive’. For variables with an Odds Ratio ≤0.83 bunched inverse variables were 
generated (e.g. no respiratory symptoms). These bunched variables exclude all 
variables of a group of symptoms (e.g. all respiratory symptoms) at the same time. 
Regarding patients with parasitaemia, 637 (44.0%) showed no respiratory symptoms 
(i.e. were negative for respiratory distress, chestindrawing, breathing difficulties, fast 
breathing, deep breathing, running nose, blocked nose and cough) at the time of 
assessment. Among patients without detected parasites this proportion of patients 
with absence of respiratory symptoms was much smaller with 1002 (25.1%) patients.  
The resulting Odds Ratios were used to decide whether the variables were handled 
as ‘potentially predictive’ for Plasmodium falciparum parasitaemia. Those variables 
providing both, an Odds Ratio of ≥1.20 and an occurrence in at least 1% of cases 






Table 6.1.  Signs and symptoms and their association with P. falciparum parasitaemia in children 
* Patients could show multiple signs or symptoms 
a CI: 95% Confidence interval 
 
 
Signs and Symptoms* 
assessed by nurse or doctor 
Patients 






95% - CIa p 
 n=5447  n=3998  n=1449    
            
 N  (%)  N (%)   N (%)    
Running Nose 3074 (56.4)  2466 (61.7)  608 (42.0) 0.44 0.39 - 0.50 <0.001 
Elevated body temperature 2025 (37.2)  1143 (28.6)  882 (60.9) 1.97 1.86 - 2.09 <0.001 
Blocked nose 762 (14.0)  631 (15.8)  131 (9.0) 0.53 0.43 - 0.64 <0.001 
Skin rash 621 (11.4)  530 (13.3)  91 (6.3) 0.43 0.34 – 4.52 <0.001 
Palmar pallor 477 (8.8)  218 (5.5)  259 (17.9) 2.80 2.38 - 3.30 <0.001 
Skin abnormalities 344 (6.3)  268 (6.7)  76 (5.2) 0.77 0.59 - 1.00 0.051 
Other skin problem 179 (3.3)  122 (3.1)  57 (3.9) 1.30 0.94 – 1.79 0.107 
Malnourished condition 136 (2.5)  110 (2.8)  26 (1.8) 0.64 0.41 - 0.99 0.047 
Prostration 115 (2.1)  61 (1.5)  54 (3.7) 2.49 1,72 - 3,62 <0.001 
Fast breathing 88 (1.6)  72 (1.8)  16 (1.1) 0.60 0.35 - 1.05 0.074 
Jaundice 82 (1.5)  35 (0.9)  47 (3.2) 3.79 2.44 - 5.90 <0.001 
Breathing difficulties 60 (1.1)  50 (1.3)  10 (0.7) 0.54 0.27 - 1.08 0.084 
Chest indrawing 59 (1.1)  46 (1.2)  13 (0.9) 0.77 0.41 - 1.44 0.426 
Respiratory distress 58 (1.1)  40 (1.0)  18 (1.2) 1.24 0.71 - 2.17 0.443 
Skin depigmentation 51 (0.9)  45 (1.1)  6 (0.4) 0.36 0.15 – 0.85 0.021 
Deep Breathing 33 (0.6)  24 (0.6)  9 (0.6) 1.03 0.48 - 2.23 0.930 
Pinch abdomen present 21 (0.4)  20 (0.5)  1 (0.1) 0.13 0.01 - 1.02 0.053 






Table 6.2 Signs and symptoms and their association with P. falciparum parasitaemia in children 
* Patients could show multiple signs or symptoms; a CI: 95% Confidence interval 
b For variables with an Odds Ratio of ≤0.83 bunched inverse variables were generated (e.g. no respiratory symptoms). These bunched  
  variables exclude all variables of a group of symptoms (e.g. all respiratory symptoms) at the same time. 
c To be positive for this (inverse) variable patients must not present malnourished condition 
d To be positive for this (inverse) variable patients must not present skin abnormalities, skin rash, skin depigmentation and other skin problem 
e To be positive for this (inverse) variable patients must not present vomiting and diarrhoea 
f To be positive for this (inverse) variable patients must not present, chestindrawing, breathing difficulties, fast breathing, running nose, blocked 
  nose, cough
Signs and Symptoms* taken 










95% - CIa P 
 n=5447  n=3998  n=1449    
            
 N  (%)  N (%)   N (%)    
Report of fever 3859 
 
(70.8)  2647 (66.2)  1212 (83.6) 2.61 2.23 – 3.04 <0.001 
Nutrition changed to poor 
feeding 
3659 (67.2)  2617 (65.5)  1042 (71.9) 1.32 1.16 – 1.50 <0.001 
Cough 3081 (56.6)  2500 (62.5)  581 (40.1) 0.40 0.35 – 0.45 <0.001 
Vomiting 1870 (34.3)  1275 (31.9)  595 (41.1) 1.48 1.31– 1.68 <0.001 
Diarrhoea 1636 (30)  1264 (31.6)  372 (25.7) 0.74 0.65 – 0.85 <0.001 
Drinking thirsty 425 (7.8)  284 (7.1)  141 (9.7) 1.40 1.14 – 1.74 0.001 
Earpain 172 (3.2)  135 (3.4)  37 (2.6) 0.74 0.51 – 1.08 0.126 
Convulsions 20 (0.4)  12 (0.3)  8 (0.6) 1.84 0.75 – 4.52 0.180 
Generated variables b  
          
No malnourishment c 5311 (97.5)  3888 (97.2)  1423 (98.2) 1.55 1.01 – 2.38 0.047 
No skin symptoms d 4687 (86.1)  3374 (84.4)  1313 (90.6) 1.79 1.47 - 2.17 <0.001 
No gastrointestinalsymptoms e 2682 (49.2)  2019 (50.5)  663 (45.8) 0.82 0.73 – 0.93 0.002 
No respiratory symptoms f 1639 (30.1)  1002 (25.1)  637 (44.0) 2.34 2.06 – 2.66 <0.001 
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3.4 Stepwise logistic regression 
To estimate which of the variables were useful for prediction of P.falciparum 
parasitaemia, backward and forward stepwise logistic regression were performed. 
Only those variables were entered in the regression, that were found to be 
‘potentially predictive’ according to the criteria mentioned above. Symptoms that met 
these criteria were prostration, palmar pallor, jaundice, respiratory distress, other skin 
problem, report of fever, elevated body temperature, nutrition change to poor feeding, 




Table 7. Result of forward and backward stepwise logistic regression with 
               variablesa from bivariate logistic regression potentially predictive for  




 Odds Ratio 95% - CI
b p 
Palmar pallor 3.06 2.49 – 3.78 <0.001 
Elevated body temperature 2.82 2.47 – 3.23 <0.001 
Report of fever 4.62 3.39 – 6.30 <0.001 
Other skin problem 2.25 1.47 – 3.47 <0.001 
Vomiting 1.33 1.16 – 1.52 <0.001 
No respiratory symptoms 2.45 2.14 – 2.81 <0.001 
No skin symptoms 1.97 1.51 – 2.56 <0.001 
No malnourishment 1.71 1.08 – 2.76 0.025 
 
Number of observations: 5447; Likelihood ration chi2 : 843.64; p= <0.0001 
 
a
‘Potentially predictive variables’ were defined as variables providing an Odds Ratio 
  of ≥1.20 and an occurrence in at least 1% of cases with present parasitaemia in  
  the bivariate logistic regression. These variables were entered in the stepwise regression. 
b
CI, 95% confidence interval 
 
 
Both parameter reduction methods revealed the same result, which is displayed in 
Table 7.Using a statistical cutoff of p ≥ 0.05 the following variables were found to be 
predictive for parasitaemia in the context of the logistic regression: Palmar pallor with 
an OR of 3.06 (95%-CI: 2.49 – 3.78; p<0.001), elevated body temperature with an 
OR of 2.82 (95%-CI: 2.47 – 3.23; p<0.001), report of fever with an OR of 4.62 (95%-
CI: 3.39 – 6.30; p<0.001), other skin problem with an OR of 2.25 (95%-CI: 1.47 – 
3.47; p<0.001), vomiting with an OR of 1.33 (95%-CI: 1.16 – 1.52; p<0.001), no 
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respiratory symptoms with an OR of 2.45 (95%-CI: 2.14 – 2.81; p<0.001), no skin 
symptoms with an OR of 1.97 (95%-CI: 1.51 – 2.56; p<0.001) and no 
malnourishment with an OR of 1.71 (95%-CI: 1.08 – 2.76; p<0.025).  
These symptoms were then entered in the Classification and regression tree (CART). 
 
3.5 Classification and Regression Tree (CART) 
The CART was performed separately for the two age groups. In children between 2-
12 months of age, the first decision was made by whether the patient was diagnosed 

















Figure 6. CART for the prediction of P. falciparum positivity in children between 2 and 
                12 months of age (n=1304) 
 
Legend: 
a Number of patients with therespective combination of variables given by the  
  branches of the decision tree 
b Number of patients positive for P. falciparumparasitaemia 
c Odds Ratio for P. falciparumparasitaemiawith the combination of variables in    





In 19 children out of 29 who presented with palmar pallor but without respiratory 
symptoms (no respiratory symptoms=yes) a P. falciparum parasitaemia was detected 
(OR=4.75). To the contrary, patients without palmar pallor, without an elevated body 
temperature (≥ 37.5°C) on admission and without any report of fever in the last five 
days had an OR of 0.14 for parasitaemia. 
Only 5 (2.0%) out of these 255 patients were tested positive for parasitaemia. 
For those children, who had a positive report of fever, the likelihood of having 
parasitaemia was slightly higher with an OR of 0.73. 
As also visible in Figure 6, not all of the variables that resulted from the stepwise 
logistic regression were used to create the decision tree of the CART-analysis. The 


















Figure 7. CART for the prediction of P. falciparum positivity in children between 12  
                and 60 months of age (n=4143) 
 
Legend: 
a Number of patients with therespective combination of variables given by the  
  branches of the decision tree 
b Number of patients positive for P. falciparumparasitaemia 
c Odds Ratio for P. falciparumparasitaemiawith the combination of variables in    
  comparison to all other combinations 
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The model used both variables indicating a fever, elevated body temperature and 
report of fever, respectively. Following the first branch of the CART and translated 
into clinical practice suggested to measure the body temperature of the patient first. If 
the body temperature was not elevated, the next question would have been for any 
history of fever, which adheres to common clinical proceeding.  
Compared to the CART for children between 12-60 months several differences were 
obvious (Figure 7). While palmar pallor was strongly predictive for parasitaemia in 
children between 2-12 months of age, it caused only small differences of the OR in 
older children where elevated body temperature was the first decisive variable. The 
lowest likelihood for a parasitaemia was found in children without elevated body 
temperature and without report of fever (OR of 0.22 for malarial parasitaemia). On 
the other hand an elevated body temperature and absence of respiratory symptoms 
resulted in the highest risk for parasitaemia (OR 2.18). 
In Table 8 data on the sensitivity and the specificity for the prediction of  
P. falciparum parasitaemia are shown for the five variables that remained in the 
CART analyses. In both age groups the proportion of children with a report of fever 
was larger than the proportion of children who were actually presenting with an 
elevated body temperature on admission.  
 
Table 8. Sensitivity and specificity of symptoms for prediction of P. falciparum  















Note: Percentage refers to the total number of patients within each age group   
a ROF=report of fever; b EBT=elevated body temperature; c NRS=no respiratory symptoms 
 
 Patients 2-12 months 12-60 months 
ROFa n (%) 1029 (78.9) 3539 (85.4) 
 Sens. / Spec. 96.0/23.8 96.8/19.6 
EBTb n (%) 465 (35) 1569 (37.9) 
 Sens. / Spec. 56.7/68.5 61.5/72.5 
Palmar Pallor n (%) 90 (6.9) 387 (9.3) 
 Sens. / Spec. 21.7/95.5 17.3/94.2 
Vomiting n (%) 549 (42.1) 1321 (31.9) 
 Sens. / Spec. 40/57.6 41.2/72.2 
NRSc n (%) 340 (26.1) 1299 (31.6) 
 Sens. / Spec. 38.9/76 44.7/74.5 
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In both age-derived models, palmar pallor had the highest specificity of all variables 




3.6 Palmar pallor and anaemia 
Each participant of the study had to provide an EDTA-blood sample for a full blood 
count and thin or thick blood film. The distribution of the clinical diagnoses revealed 
anaemia as a common diagnosis and CART highlighted the predictive value of 
palmar pallor for P. falciparum parasitaemia. Thus haemoglobin (Hb) concentrations 
of the study participants were examined more closely. In Figure 8 the distribution of 


















Figure 8: Distribution of Hb-levels in 5447 children of all ages (2-60 months) 
 
Figure 9 displays the proportion of children infected with Plasmodium falciparum 
within each range of haemoglobin and revealed a clear dependency between the Hb-
level and the infection status as children with parasitaemia had overall lower Hb-



















Figure 9. Proportion of patients with P. falciparum parasitaemia in relation to the 
                distribution of haemoglobin levels 
 
 
Solely with these figures it was possible to estimate that the majority of patients 
suffered from at least moderate anaemia. Setting a threshold of Hb ≤11 g/dl, Figure 
10 shows the proportion of anaemic children in different ages and it is clearly visible 
that prevalence of anaemia was inversely correlated with the age of the patients. For 
this description children were stratified by age using strata of 10 to 12 months. While 
the proportion of children suffering from anaemia was 76.8% in children aged 2-12 
months, it was 64.7% in children in the age between 24 and 36 months and 57.9% in 
children aged 48-60 months (Figure 10). 
The symptom palmar pallor was noticed in 477 (8.8%) of all patients. In the CART it 
was used as one of the major predictors for present parasitaemia.  
To confirm that the predictive value of palmar pallor is applicable to clinical routine it 
was necessary to investigate whether the symptom palmar pallor was able to indicate 
decreased haemoglobin-levels. As expected, Hb-levels were indeed significantly 





















Figure 10.  Proportion of mild anaemia in children of different ages  
 
 
Children aged between 2 and 12 months had a mean Hb level of 7.7 g/dl if palmar 
pallor was present and 10.2 g/dl if not (p<0.001). Children aged between 12 and 60 
months who were presenting with palmar pallor and those without had a mean Hb of 
8.1 g/dl and 10.4 g/dl, respectively (p<0.001).  
To discover potiential over-representation of palmar pallor due to the effect of multipe 
visits of single individuals a McNemar-test was used (Appendix Table A1). The 
McNemar-test showed no heterogeneity (p=0.342) for the symptom palmar pallor 
between patients who had only one visit to the OPD and those patients who came for 
more than one time.  
Additionally, an alternative CART was created for both age groups containing only 























Figure 11. Distribution of haemoglobin levels in patients of different ages with and  
                  without palmar pallor 
Legend:  
p-value was calculated assuming a Student’s t distribution 
 
 
3.7 Classification and comparison of CART and IMCI 
To gain more knowledge of the quality of the CART-model as a clinical algorithm it 
was compared to the Integrated Management of Childhood Illness – algorithm which 
is the main guideline in most African countries today. 
For calculation of sensitivity. specificity, positive- and negative predictive value, a 
logistic regression model was created containing all variables used in the IMCI–
algorithm and the CART, respectively. Both age groups were regarded separately. If 
applied to the population of children between 2-12 months of age in the present 
study, the IMCI algorithm would have resulted in a much higher sensitivity of 97.2% 
than the CART (6.7%), but would have remained unspecific in the prediction of 
parasitaemia with a specificity of 22.2% versus 99.6% in the CART (Table 9). The 
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positive predictive value was higher for the CART with 75.0% compared to 16.7% for 
the IMCI-algorithm. 
For the older children between 12-60 months of age these relations were decreasing, 
as the IMCI-algorithm provided a sensitivity of 55.6% and a specificity of 73.4% vs. 
37.7% and 91.4% for the CART, respectively. 
 
 
Table 9: Classification and comparison of CART and IMCI algorithm for the  
              sensitivity and specificity of the prediction of P. falciparum positivity 
 
Age (months) Model Sensitivity (%) Specificity (%) PPVc (%) NPVd (%) 
2-12 IMCI-algorithma 97.2 22.2 16.7 98.0 
(n=1304) CARTb 6.7 99.6 75.0 87.0 
12-60 IMCI-algorithma 55.6 73.4 48.0 78.9 
(n=4143) CARTb 37.7 91.4 65.8 76.9 
 
a IMCI-algorithm for identification of children with malaria in high-risk areas: Fever by  
  history or feeling hot/elevated body temperature of ≥ 37.5°C on admission and/or some  
  or severe palmar pallor.  
b CART: For calculation only those variables were used, which were included in  
  the CART for the certain age group 
c PPV = Positive predictive value 




Still, the CART provided higher positive predictive values (65.8% vs. 48.0%). 
Overall, the CART resulted in much higher specificities and higher positive predictive 
values for prediction of malarial parasitaemia in comparison to the IMCI-model, which 
provided higher sensitivities and negative predictive values. 
 
3.8 Malnourishment 
As interactions between a malnourished condition of children and malarial infections 
as well as anaemia in particular is well described in literature, nutritional deficiencies 
were recorded by weighting and measuring the height of every patient who attended 
the OPD. The results are provided as additional information in the appendix 
(Appendix Table A2 & A3). Z-scores for undernutrition (weight-for-age z-score) and 
wasting (weight-for-height z-score) were calculated. Underweight and wasting were 
defined as a z-score of -2 standard deviations (SDs) below the corresponding 
median. As visible in Table A2, undernutrition was overall equally distributed among 
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children between 2 months and 48 months of age. Between 10.2% and 12.0% of 
these patients fulfilled the definition of ‘underweight for age’. Older children (48-60 
months) were more affected by underweight, with a fraction of 16.6% with -2 SDs 
below the median. 
Wasting, measured as a weight-for-age z-score of -2 SDs or below, rather affected 


























The aim of the present study was to generate an age-derived clinical algorithm to 
predict P. falciparum parasitaemia in children between 2 and 60 months of age. By 
using a Classification and regression tree (CART) analysis simple clinical signs and 
symptoms should be discovered which may enhance the clinical decision making 
whether to treat patients suspected of having malaria or not. 
As our results showed, the CART algorithm increased prediction specificity for 
malarial parasitaemia in comparison to a simple combination of single parameters. 
Specificity and positive predictive value for P. falciparum parasitaemia of the CART 
outperformed the IMCI-algorithm. The predictive value of the symptoms fever and 
palmar pallor was age-dependent. It was possible to show that the symptom palmar 
pallor is able to indicate significant lower haemoglobin - concentrations even in a 
population with a high prevalence of anaemia. Thus, use of pallor as a possible sign 
of anaemia due to malaria should be highlighted in health worker training. 
However, despite the good specificity of the CART it is not possible to implement it in 
clinical routine due to a lack of sensitivity. By making treatment decisions only based 
on the application of the CART too many sick patients would have been missed. 
Therefore the use of clinical algorithms cannot replace laboratory diagnostics or rapid 
diagnostic tests (RDT). If these diagnostics are not available children suspected of 
malaria have to be treated presumptively. 
 
To be able to provide reliable results the study was carried out in an area that is 
exemplary for a setting with high malaria transmission during the whole year. 
Gathered data from initially over 12.000 enrolled patients was condensed to a 
dataset, which is highly consistent regarding all analyzed variables. Apart from earlier 
studies, we only assessed children between 2-60 months of age attending an OPD 
for any episode of illness within the study period. This age group is the one at highest 
risk of dying due to malaria (Eliades et al. 2006, World Health Organization 2008a). 
 
4.1 Parasitaemia and Malaria 
To gain more knowledge about the role of the symptom fever for the prediction of 
malarial parasitaemia it was decided not to use ‘fever’ or a ‘history of fever’ as an 
inclusion criterion. Accordingly, the primary outcome was defined as Plasmodium 
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falciparum parasitaemia of any density instead of ‘clinical malaria’, which is 
commonly defined as presence of parasitaemia and ‘fever’ or a ‘history of fever’ 
(Bojang et al. 2000, Muhe et al. 1999, Redd et al. 1996). 
With an overall prevalence of 26.6%, we measured a comparatively low level of 
Plasmodium parasitaemia (Bouyou-Akotet et al. 2009, Gay-Andrieu et al. 2005, 
Guinovart et al. 2008, Ronald et al. 2006). A study conducted in northern Ghana in 
the year 2006, showed a prevalence of 82% in the rainy season and 75% in the dry 
season (Ehrhardt et al. 2006). Researchers in Tanzania even found over 90% of 
children aging one to four years infected with P. falciparum parasites and a study 
from Togo revealed a prevalence of 62.2% (Eliades et al. 2006, Smith et al. 1993). 
Although a cross-sectional survey conducted in Kumasi, Ghana, underlined that 
malaria transmission can vary widely across certain areas (Ronald et al. 2006), two 
other reasons may explain the relatively low prevalence in the present study: First, 
we enrolled all children attending the OPD, disregarding any prerequisites. If we had 
used any form of fever definition as an inclusion criterion the prevalence would have 
been much higher. Secondly, there is increasing evidence of declining malaria 
transmission in Africa in the last years (World Health Organization 2010b, Bouyou-
Akotet et al. 2009b, Ceesay et al. 2010). These reports may not at least reflect the 
efforts of the WHO and the affected countries themselves to reduce the impact of 
malaria by improving overall health capacities (e.g. distribution of long-lasting 
insecticidal nets (LLINs)) over the last decade (World Health Organization 2008d). 
Regarding the age-dependent prevalence of P.falciparum parasitaemia our results 
were in line with previous findings. Due to the increasing susceptibility after the first 
four to six months of life, prevalence of malarial infections is also rising in older 
children (Eliades et al. 2006). 
As visible in Figure 4 and 5 the proportion of patients with parasitaemia was higher 
than the proportion of patients with defined ‘clinical malaria’, except in children 
between 2-12 months of age. This gap was owed to the significant number of 
patients that presented to the OPD without an elevated body temperature and 
without a report of fever. 
 
4.2 Methodology 
For the statistical analysis a patient was defined as an individual visiting the OPD. To 
avoid inclusion of an individual with the same episode of illness for a second time a 
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minimum latency of 14 days since the last visit was set. Follow-up visits within these 
14 days were treated as reviews and were not included in the analysis. 
Assessment of the children was performed by three pediatricians and several study 
nurses. As the entire study was conducted over a period of almost three years it was 
implemented in daily clinical routine. Thus, it was not possible to assess every patient 
twice to get information about possibly existing inter-observer bias. To minimize 
confounding effects during the assessment we used a case report form with pre-
defined criteria. However, it was possible for the doctor to state additional 
information, which was later transformed into binary variables.  
The distribution of diagnoses made by the assessing doctors (Table 5) reflected 
current statistics of UNICEF (Unicef 2012). Usually, laboratory results should have 
been available for the doctor before he made the diagnosis. But as the big difference 
between the number of patients with the clinical diagnosis ‘malaria’ (50.6% of all 
children) and the number of patients with detected P. falciparum parasitaemia 
(26.6%) demonstrated a high proportion of patients was diagnosed false positive. 
The most likely explanation for this discrepancy may be the non-availability of the test 
results at the time of making the diagnosis. But, however, non-adherence to negative 
test results also has to be taken into account. Earlier investigations of the adherence 
to negative test results of RDT’s in this context have shown that physicians tended to 
ignore negative test results and treated patients with anti-malarials assuming the test 
result to be wrong (Ansah et al. 2010, Bisoffi et al. 2009, Kyabayinze et al. 2010). 
However, we used parasite microscopy and we assume that the physicians in Agogo 
generally trusted the work of their laboratory, which worked on a high standard level. 
 
4.3 Predictive signs and symptoms for P. falciparum parasitaemia 
The first step of the analysis was to verify, whether single independent variables 
could be helpful to predict a P.falciparum parasitaemia in children who were 
presenting to the OPD. In the present study these independent variables were mainly 
simple signs and symptoms, which can be assessed without any special medical 
equipment. Putting these signs in bivariate logistic regression, Odds Ratios for the 
outcome P. falciparum parasitaemia were calculated. 
As already mentioned above, a report of fever and an elevated body temperature 
were also treated as independent variables. Regarding Table 5.1 and 5.2 it is 
obvious that we particularly assessed symptoms, which reflect less severe 
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conditions. Symptoms like unconsciousness, convulsions or cyanosis were overall 
less frequently observed, which may be explained by the study design and setting: 
All children attending the OPD, for instance also children who suffered from minor 
illness (e.g. a common cold), were included in the calculation. Further the population 
of Agogo is used to medical research in the Presbyterian Hospital, which could have 
resulted in enhanced health care seeking behavior. From this point of view it is likely, 
that most of the enrolled patients with parasitaemia were assessed before their 
condition became worse. 
While some prior studies dealt with symptoms in critically ill children in order to 
predict severe illness or fatal outcome (Dzeing-Ella et al. 2005, Marsh et al. 1995, 
Mockenhaupt et al. 2004), others were solely focused on clinical features predicting 
malaria (Bojang et al. 2000, Muhe et al. 1999, Mwangi et al. 2005). Results of the 
latter were not entirely consistent as their predictive value depended on certain 
settings: 
In those studies where it was not part of the definition of the outcome (‘clinical 
malaria’) or an inclusion criterion, fever or a history of fever was strongly associated 
with malarial parasitaemia (Genton et al. 1994, Redd et al. 1996). In the present 
model fever was still used as a substantial predictor but showed i) different predictive 
value across the age groups (lower in young children, higher in older children) and 
was ii) outperformed by the symptom palmar pallor especially in young children. The 
presence of respiratory symptoms like cough or running nose commonly expresses 
upper respiratory tract infections, which can be easily accompanied by fever and was 
consequently not found to be associated with malarial parasitaemia (Muhe et al. 
1999, Mwangi et al. 2005). To the contrast signs like respiratory distress or fast 
breathing were recognized as signs of ‘severity of illness’ and were more often 
associated with a positive malaria parasite status (Muhe et al. 1999, Schellenberg et 
al. 1999). Particularly respiratory distress is discussed to be an indicator for 
metabolic acidosis and/or developing heart failure due to severe malarial anaemia 
(Bojang et al. 2000, Marsh et al. 1995). 
In the present study mild respiratory symptoms were indeed some of the most 
frequent since 56.6 % of patients were presenting with cough and 56.4% with a 
running nose. Bunched together in the variable no respiratory symptoms it was 
possible to use the absence of respiratory symptoms as a predictor for malarial 
parasitaemia or, in other words: Presence of respiratory symptomns reduced the 
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likelihood of the presence of parasitaemia and increased the likelihood of presence of 
an respiratory disease, which led to the OPD visit. 
For other symptoms findings varied between different studies: Dehydration and poor 
feeding were found to be negatively associated with malaria in a study of Muhe et al. 
in 1999, while other researchers even highlighted the role of dehydration 
(Schellenberg et al. 1999). A poor nutritional status was described to be positively 
correlated with malaria (Muhe et al. 1999, Schellenberg et al. 1999). 
Enlargement of spleen and/or liver was found to be predictive in most of the studies 
(Bojang et al. 2000, Muhe et al. 1999, Olaleye et al. 1998) but research also showed 
that correct assessment of spleno- and hepatomegaly could be difficult for health 
workers (Grover et al. 1993). For this reason we waived to use these signs. 
At the present study site we assessed several symptoms that were not covered by 
prior studies mentioned above (e.g. earpain, skin symptoms). Furthermore some of 
the signs and symptoms in our analysis, like respiratory symptoms and skin 
symptoms initially provided ORs that seemed to have a protective value for a 
diagnosis of malarial parasitaemia. Given this, presence of skin symptoms (e.g. skin 
rash) was an expression of another conditions (e.g. measles) and, in turn, absence of 
this symptom in a febrile child could guide the way to a parasitaemia. Thus, for these 
variables inverse variables were created to keep them in the analysis as a potential 
predictor. 
From the initial 30 covariates in Table 6.1 and 6.2, which were put in bivariate logistic 
regression as a sort of prescreening to generate a set of variables that provide a 
certain ‘a priori likelihood ‘ to predict P. falciparum parasitaemia, 13 satisfied the 
criterion of an Odds Ratio of ≥1.2 and an occurrence of ≥1% in parasite positive 
patients. These were handled as potentially predictive. As 13 variables were still too 
many to provide a useful model that is easy to interpret we used the stepwise logistic 
regression as a method of ‘assessment of fit’ (Lemeshow and Hosmer 1982). This 
parameter reduction technique enabled us to develop a set of variables where only 
those variables were included that have the best fit to each other (Table 6). To 
ensure consistency stepwise logistic regression was calculated in both directions – 
as forward and backward logistic regression. Both calculations revealed the same set 




4.4 Classification and Regression Tree (CART) 
In contrast to earlier studies, where multivariate logistic regression was used to trace 
for predictive variables for malaria (Chandramohan et al. 2001, Muhe et al. 1999, 
Mwangi et al. 2005), we used a Classification and regression tree – analysis, which is 
a completely different approach. Using multivariate logistic regression alone it is not 
possible to explore the relationship between different independent variables and their 
relative importance (Thang et al. 2008). Logistic regression is also not able to rank 
risk factors according to their importance. Therefore, we decided to use the CART, 
which is a non-linear and non-parametric alternative for regression and classification 
problems (Thang et al. 2008). Gaudart et al. described the nature of CART as “fitted 
by binary recursive portioning of a multidimensional covariate space in which the 
dataset is successively split into increasingly homogeneous subsets until a specified 
criterion is stratified” (Gaudart et al. 2005, page 2). 
Regression trees are a hierarchical attempt that provides a more flexible relationship 
between variables and is even able to deal with multi-collinearity and outliers. It is 
also possible to handle missing values as own subgroups and therewith separate 
them from further analysis (Saegerman et al. 2004). However, we did not use the 
latter, as all patients with missing values for a certain set of variables were excluded 
from our dataset. CART is easy to interprete even for non-statisticians and has 
successfully been proven applicable in different medical studies (Bachur and Harper 
2001, Crichton et al. 1997, Zhang et al. 1996). Nevertheless some researchers also 
mentioned disadvantages of the method, mainly caused by the strong hierarchical 
orientation. Speybroeck doubted that it would be possible to discover simple decision 
rules by “tree-growing”. Furthermore they raised the concern that subgroups created 
by the CART may be hard to interpret and net effects of independent variables are 
frequently not discovered (Speybroeck 2011).  
For the calculation of the CART in the present study the variables palmar pallor, 
elevated body temperature, report of fever, other skin problem, vomiting, no 
respiratory symptoms, no skin symptoms and no malnourishment were entered. The 
contradictory selection of the conflictive variables other skin problem and no skin 
symptoms was abolished as the CART did not use one of these variables. 
Instead, CART used the variables palmar pallor, elevated body temperature, report of 
fever, no respiratory symptoms, and vomiting for creating a decision tree for both age 
groups. The model for patients between 2-12 months of age is obviously less 
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complex than the model for patients between 12-60 months of age, which may partly 
be owed to the higher number of patients in the second group leading to a greater 
variety of clinical presentations. Regarding the structure of the models they are 
clearly orientated on clinical decision making as, for instance, in the model for the 
older children the elevated body temperature should be assessed first followed by 
the question for any report of fever. Although age dependent differences of certain 
variables are quite obvious, there is also evidence throughout both models that the 
variables alternate in their predictive value disregarding the age of patient they are 
used for. Whilst the presentation of palmar pallor was causing big differences in the 
risk of having malarial parasitaemia especially in younger patients, the variable 
vomiting was only responsible for little changes of the Odds ratio. Nevertheless, 
vomiting reveled a relatively high sensitivity and specificity for the prediction of 
parasitaemia (Table 8). 
 
4.5 Age-dependent differences in the predictive value of fever and 
palmar pallor 
 
The main difference between the two age-derived CART models was enunciated in 
the predictive value of the symptoms report of fever,elevated body temperature and 
palmar pallor. While the predictive value of fever was increasing with the age of the 
patients, the variable palmar pallor was the most decisive sign in the youngest 
children between 2-12 months of age. For those children positive assessment of 
palmar pallor and absence of any respiratory symptoms sufficed to result in an Odds 
ratio of 4.75 for having malarial parasitaemia (Figure 6). In the CART for the older 
children palmar pallor was responsible for only small differences of the Odds ratio 
and it was not involved in every single decision. 
To gain more knowledge about the predictive role of the symptom fever in the 
diagnosis of P. falciparum malaria we used two definitions of fever. Using the history 
of fever given by the legal guardian of the child has been proven to lead to significant 
overdiagnosis if it equals the case definition of malaria in high transmission areas 
(Okiro and Snow 2010, Reyburn et al. 2004, Zurovac and Rowe 2006a). In this study 
legal guardians of 66.2% of children without malaria parasites in their blood reported 
any episode of fever or feeling hot. Exclusive application of fever as decision criterion 
for treatment would have consequently resulted in a false treatment of 2647 children 
with anti-malarials. Beside the economic impact of unnecessary medication and the 
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indisputable risk of overseeing other underlying causes of the fever, when focusing 
on the diagnosis malaria, this strategy has its justification only under certain 
circumstances. Thus, to date only health workers in settings where no laboratory or 
RDT–diagnosis is possible are asked to treat presumptively (World Health 
Organization 2010d).  
Statements about the validity of the symptom report of fever are difficult. Studies 
have shown that mothers are indeed able to detect an elevated body temperature in 
their children with sensitivities up to 74%, which makes it reasonable to consider a 
report of fever as a reliable information (Wammanda and Onazi 2009, Ye et al. 
2007). An onset of fever has also frequently shown to be the trigger for seeking help 
from health facilities (McCombie 1996, Molyneux et al. 1999). On the other hand 
clear definitions should ensure that the term fever is not ambiguously used as studies 
also discovered that in some societies the term fever is used as a synonym for “a 
general state of poor health” (Einterz and Bates 1997). To objectify the presence of 
fever every child’s temperature was measured on admission and the variable 
elevated body temperature was created. As visible from Table 4 there is a noticeable 
gap between the numbers of patients with a report of fever and an elevated body 
temperature on admission. This may be particularly owed to the broad use of 
antipyretics, as 73.2% of all children enrolled in this study received Paracetamol prior 
to their visit. 
This confounding effect of antipyretic use makes it difficult to rely only on an elevated 
body temperature on admission and in turn necessary to assess, whether a child had 
a prior history of fever. The CART for children between 12-60 months of age reflects 
this attempt in a solid way. In settings where high numbers of parasite positive 
patients are assumed it is necessary to use the most sensitive variable to catch as 
many sick patients as possible. Table 8 underlines that a report of fever satisfy this 
criterion, although comparison of the specificity between elevated body temperature 
and report of fever indicates that a significant number of patients with a positive 
report of fever had a fever of other origin or was false positive for this variable.  
Apart from the validity of the variables indicating a fever themselves some raised the 
question, if fever can serve as an indicator for malaria any longer (D'Acremont et al. 
2009) as prevalences of Plasmodium falciparum transmission intensity have been 
reported to decline in several parts of Africa (Hay et al. 2009, World Health 
Organization 2008d). This would consequently result in larger proportions of other 
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conditions possibly accompanied with similar symptoms like malaria (Reddy et al. 
2010, Ukwaja et al. 2011), needing different diagnostic and treatment strategies 
(Brent et al. 2006) (see section 4.7). 
 
The second symptom with a clear age-dependency in this study was palmar pallor. 
The CART for children aged between 12-60 months revealed this symptom as the 
most decisive variable in this age group. Pallor due to anaemia is a common clinical 
sign in SSA (Desai et al. 2005, Ronald et al. 2006, World Health Organization 
2008b), in the present study it was noticed in 8.8% of all cases.  
Defining anaemia by setting a haemoglobin (Hb) cut – off of  ≤11.0 g/dl (Quinto et al. 
2006), up to 76.8% of patients in the group of children aged between 2-12 months 
were found to be anaemic according to their full blood count (Figure 10). Compared 
to other studies this appears to be a very high prevalence (Akhwale et al. 2004, 
Magalhaes and Clements 2011). Various causes have been described to be involved 
in the development of anaemia. While iron deficiency was frequently described to be 
the main contributor to anaemia in west Africa (Kraemer and Zimmermann 2007, 
World Health Organization 2001), infectious diseases, malnutrition and 
haemoglobinpathies are other common causes (Bates et al. 2007, Means 2000, 
Morris et al. 2006). The mechanism of anaemia due to infectious diseases mainly 
includes three processes: Shortened red cell survival, impaired Erythropoetin (EPO) 
production and impaired mobilization of the reticuloendothelial system to iron stores 
(Cartwright 1966, Means 2000). In acute malaria anaemia is a hybrid between 
predominant haemolytic anaemia and anaemia of infectious diseases as increased 
cytokine production and impaired EPO response also seem to be involved (el 
Hassan et al. 1997). 
Nutritional deficiencies are known to play an important role in childhood anaemia too: 
Verhoef and colleagues could illustrate with their findings that malnutrition is 
associated with more severe occurrence of malarial anaemia (Verhoef et al. 2002). 
Desai et al. also made stunting and concurrent fever responsible for significantly 
lower mean haemoglobin levels (Desai et al. 2005). Except in children aged 48-60 
months, where the percentage was higher, the proportion of children suffering from 
undernutrition was around 10% in the present study, which is relatively low compared 
to figures from other areas (Beiersmann et al. 2012). De Onis et al. even forecasted 
an estimated average increase of underweight in sub-saharan Africa from 24.0% to 
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26.8% between the years of 1990 and 2015 (de Onis et al. 2004). The fact that 
children, especially in tropical areas, of West Africa are often less effected by severe 
undernutrition may be due to the relatively good access to high-carbohydrate 
nourishment (e.g. yams, cassava, rice, corn). However, there is still a lack in  
micronutrients like iron, folate, zinc, the B vitamins and calcium. This consequently 
results in specific malnourishment of these substrates and is probably an explanation 
for the large fraction of anaemia (e.g. through a lack of iron and B12 vitamin) in our 
population. In bivariate logistic regression only one variable reflecting the status of 
chronic undernutrition was related to the outcome. A malnourished condition was 
associated with P. flaciparum parasitaemia with an OR of 0.64, the inverse variable 
in turn resolved in an OR of 1.55. That said, the variable nutrition change to poor 
feeding, which was predictive for parasitaemia with an OR of 1.32, must be seen as 
an expression of short term change of behavior in a sick child in general.  
Studies concerning a relationship between malnourishment and malaria susceptibility 
gave mixed results in the past. Deen et al. stated in his paper, that neither wasting 
nor undernutrition influenced susceptibility to malaria, but children, who were stunted 
experienced malaria attacks more frequently, than children, who were not stunted 
(Deen et al. 2002). In contrast to this, an earlier study, conducted by Genton et al. 
found, that stunting protects against falciparum malaria. The authors explained their 
findings with an improved ability of malnourished children to produce certain 
cytokines in response to malaria antigens (Genton et al. 1998). After all, it is 
commonly undisputed that children with severe protein malnutrition have an 
significantly increased risk to die from malaria, compared to those children, who are 
in good nutritional state (Caulfield et al. 2004, Mockenhaupt et al. 2004, Muller et al. 
2003). 
In the setting of this study, palmar pallor was assessed by experienced pediatricians. 
Investigation of full blood counts showed that the sign palmar pallor could predict 
significant lower levels of hemoglobin even in a population with a very high 
prevalence of anaemia. Indeed, children with palmar pallor had significantly lower 
Hb-levels than those who were not diagnosed as being pale on their palms (Figure 
11). The quality of the palms as a site to reliably predict pallor was confirmed in 
earlier studies. Chalco et al. showed that the best predictor for a level of 
haemoglobine ≤11 g/dl was palmar pallor, conjunctival pallor and nailbed pallor (in 
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descending order). For an Hb ≤8 g/dl only plamar pallor gained sensitivities of >80% 
(Chalco et al. 2005). 
Previous studies showed diverse results on the ability of health workers to recognize 
pallor (Chalco et al. 2005, Kalantri et al. 2010, Strobach et al. 1988). Health workers 
in high malaria transmission areas had less difficulties (Weber et al. 1997).  
As we regarded patient visits instead of individuals in this study, it was possible for 
an individual to attend the OPD for several times within the study period. To exclude 
any confounding effect due to multiple visits of single individuals with a personal 
predisposition for anaemia leading to an overrepresentation of the symptom palmar 
pallor, multiple visits of individuals were also analyzed. The McNemar-test showed 
no heterogeneity (p=0.342) for the symptom palmar pallor between patients who had 
only one visit to the OPD and those patients who came for more than one time (Table 
A1). An alternative CART that included only the first visit of every individual also 
showed no deviance from the original models (Figure A1 and A2). 
 
In conclusion, we could show that palmar pallor is a reliable sign to predict P. 
falciparum parasitaemia in the context of an algorithm, especially in children between 
2-12 months of age. The sign is eligible to detect Hb levels of ≤11 g/dl even in a 
population with a high prevalence of anaemia. It is therefore reasonable to introduce 
palmar pallor to health workers as a sign not only for anaemia but also for malarial 
parasitaemia. Because of a lack in sensitivity it is however not possible to use the 
sign to rule out a parasitaemia. The high prevalence of anaemia in the study 
population may be due to a combination of malnourishment of micronutrients and 
malaria infections. Although it was not possible to measure the levels of iron, B12 
vitamin etc., it is unlikely that P. falciparum parasitaemia (with a overall prevalence of 
26.6%) is solely responsible for such a high prevalence of anaemia. 
 
4.6 Comparison of CART to IMCI and other algorithms 
The subjacent aim of the quest for the best clinical algorithm is the biggest challenge 
at a time. An optimal algorithm should reliably detect sick patients with high 
sensitivity. It should also enable the physician to distinguish between different 
illnesses, i.e. provide a high specificity. In addition it should be easy to use, consist of 
simple criteria and minimize the possibility of inter-observer bias. 
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Research in the context of malaria has shown that most attempts could not fulfill 
these high standard requirements. Either, the algorithms lacked in sensitivity or 
specificity or the signs applied were too difficult to assess, i.e. necessary technical 
equipment was not available. Chandramohan et al. gathered data from articles about 
ten algorithms for diagnosing clinical malaria (Chandramohan et al. 2002). With a 
closer look on these algorithms, it is noticeable, that the majority of researchers 
worked with a complex set of signs and symptoms. Most of them used logistic 
regression models to trace for predictive symptoms.  
Latest published data about trials of establishing algorithms dates from 2002 and 
2005 (Chandramohan et al. 2002, Mwangi et al. 2005). Both of these studies, which 
were conducted in areas of medium and seasonal Plasmodium transmission, 
contained of a set of 18 to 19 signs and symptoms that have to be assessed and 
calculated for application of the algorithm. 
Mwangi and colleagues calculated a score for each individual using a simple count of 
symptoms that were found to be predictive. For children under five years of age, the 
score that gave the best values for sensitivity and specificity was found to be 10. 
Estimated sensitivity and specificity were 79.6% and 55.5% respectively. The PPV 
was calculated to be 63.6%, the NPV was 73.6% (Mwangi et al. 2005). Although 
these values partly outperformed the IMCI – algorithm, it is important to bear in mind 
that transmission of a complex algorithm such like this is likely to cause problems if 
used by health workers.  
Bojang et al. (Bojang et al. 2000), who worked with an algorithm established by 
Olaleye et al. in 1998 (Olaleye et al. 1998),  gained a sensitivity of 88% and a 
specificity of 62% using an algorithm, which requires presence of 7 predictive 
variables. The pattern of signs and symptoms was similar to the study of Mwangi. 
The comparability of most of the studies is limited as research settings differ in 
methods, endemicity of the study area, age of the study population and outcome. 
Some studies were carried out with only few participants (Gay-Andrieu et al. 2005, 
Yacoub et al. 2005), amother study was a meta-analysis (Chandramohan et al. 
2002). Although less affected by malaria due to matermnal protection, there were 
more studies conducted for infants < 2 months (Jeena et al. 2008, Yeboah-Antwi et 
al. 2008, Young Infants Clinical Signs Study Group 2008), than for children between 
6 months and five years of age. 
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The Integrated Management of Childhood Illness Programme is the best known and 
most widespread approach for improving childhood health. In its Guidelines for the 
treatment of malaria the WHO until 2010 recommended immediate presumptive 
treatment of all patients suspected of malaria until 2010 (World Health Organization 
2010c). Following this approach all children living in high transmission areas 
presenting to a health facility with an elevated body temperature or a history of fever 
were treated with antimalarials. In view of the high risk of rapid death due to malarial 
parasitaemia particularly in young children this approach was the most sensitive and 
safest way to deal with high prevalences of malarial infections in endemic areas. 
Mwangi et al. compared applied the IMCI - algorithm to their population and 
calculated a sensitivity and specificity for the diagnosis of malaria of 58.4% and 
67.6%, respectively (Mwangi et al. 2005). Beyond the population of the present study 
IMCI would have resulted in a much higher sensitivitiy of 97.2 % for children aged 2-
12 months and 55.6% for children aged 12-60 months, respectively. Especially in the 
group of the youngest children application of the IMCI-model would have resulted in 
only very few patients with present parasitaemia who were mistakenly not treated. 
The vast discrepancy in sensitivity of 38.8% between the study of Mwangi et al. and 
the present study can be regarded as an indication for the aggravated comparability 
of certain studies due to substantially different settings. In high – transmission areas 
the IMCI would have resulted in much higher sensitivities as calculated by Mwang 
and collegues. Further, they conducted a household – survey where health workers 
catched symptomatic children at home, all participants lived in areas of low malaria 
transmission (10-53 infective bites per person per year) and fever was used as 
inclusion criteria. 
In the CART five signs and symptoms were applied to both age groups. It was 
possible to confirm that higher developed algorithms are able to provide much higher 
specificities, when compared to the IMCI-algorithm but lack in sensitivity. For children 
between 2 and 12 months IMCI gave a sensitivity of 97.2% and a specificity of 
22.2%, CART provided 6.7% and 99.6%, respectively.  
The symptom palmar pallor revealed high age-dependent specificity but as well as 
for the CART-models the sensitivity was very low. Vital for the decision of the health 
workers and the health of the patient are the predictive values, which are dependent 
on the prevalence of the outcome. With decreasing prevalence of malaria the 
negative predictive value will increase and the positive predictive value will decrease 
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given the same sensitivity and specificity of the algorithm. Compared to the IMCI-
algorithm the positive predictive value (PPV) was higher with 75.0% for children 
between 2-12 months and 65.8% for children between 12-60 months when applying 
the CART.  
However, comparison of the CART to IMCI-model may be aggravated as the 
outcome in the present study was P. falciparum parasitaemia and IMCI mainly 
targets ‘clinical malaria’. 
Concluding the principal findings it is obvious that the hierarchical CART-based 
decision algorithm is able to increase the prediction specificity for malarial 
parasitaemia in comparison to a simple combination of single parameters. Despite of 
a good specificity of the best model, a significant proportion of children with malaria 
would have been missed with this clinical algorithm. Particularly beyond the youngest 
children who are at highest risk of dying rapidly, significant false negative rates are 
unacceptable. Wherever possible laboratory confirmed diagnosis or use of RDTs 
should be striven for. In case of unavailability of these diagnostics, presumptive 
treatment of all children suspected of having malaria is necessary. 
 
4.7 Clinical relevance of algorithms and future challenges in malaria    
diagnostic 
 
Clinical algorithms are only one potential part of the clinical process in the 
management of a certain disease or condition. Thus, bringing the evaluation of the 
practical use of clinical algorithms in context with the intended diagnosis and 
treatment strategies is necessary. For children with an episode of fever who live in 
high transmission areas presumptive treatment for malaria was promoted for a long 
time by the WHO. As already stated above, this strategy fits the comprehensible 
desire for optimal protection of those children who are at the highest risk of dying.  
During the last years malaria transmission rates are reported to decline and reliable 
rapid diagnostic tests have been made widely available and can adequately replace 
parasite microscopy. Consequently, the WHO changed its recommendation for 
malaria treatment to a general “test-and-treat” strategy in 2010 (Graz et al. 2011): 
Only in settings where parasitological confirmation is not possible, presumptive 
treatment should be still performed. 
At which point are clinical algorithms now interfering with this policy change? 
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Responding to this question requires a closer look on the arguments for symptom-
based treatment on the one and parasite-based treatment on the other hand. 
Proponents of the change to general parasite confirmed treatment mainly refer to 
three points: i) a significant decline of the number of fevers due to malaria in former 
high transmission areas, ii) the availability of reliable RDTs andiii) an increased 
likelihood of missing other diseases, when focusing on the diagnosis ‘malaria’. 
As figures of the last years show, some of the formerly high transmission areas 
turned into moderate or low transmission areas (Ceesay et al. 2010, Guerra et al. 
2008), which consequently results in inappropriate use of anti-malarials in more and 
more cases, if treatment is presumptive. With declining transmission of malaria the 
probability of an episode of fever to be due to malaria parasites is also decreasing. In 
the year 2010 Gething et al. published their comparison of the total number of 
paediatric fever cases seeking treatment in the public sector in Africa and the number 
of children really been affected by malaria parasites. According to this spatial 
analysis 43% of all children seeking medical help were infected with P.falciparum, 
which would have resulted in 104 million cases of over-treatment in the year 2007 if 
following the presumptive treatment strategy. Albeit, the largest differences between 
malarial and non-malarial fever cases were found in countries of unstable or low 
transmission (Gething et al. 2010). 
Rapid diagnostic tests have been proven to deliver comparable performance to 
professional microscopy (Ochola et al. 2006) and use in low standard settings was 
described to be sufficient (Abeku et al. 2008, Bharti et al. 2008). The diagnostic use 
of RDTs depends on the prevalence of malaria: In settings with a high prevalence of 
malarial infections the test will not provide any useful information, as most of the 
tested patients will be parasite positive and it is not possible to differentiate between 
symptomatic and asymptomatic parasitaemia nor to exclude other diseases as the 
cause of fever (Graz et al. 2011). Apart from that the use of RDTs in settings such 
like this is not cost-effective, particularly not if the costs of the test exceed the costs 
of the medication (Lubell et al. 2008, Msellem et al. 2009).  
Although overall data about test-related action of health workers is rather ambiguous, 
the over-reliance to positive test results has frequently been described as a major 
barrier to better results in overall mortality. Especially when treating physicians or 
health workers focus on malaria as the cause of a fever and refrain other diagnostics 
(Graz et al. 2011, Willcox et al. 2009). Reyburn et al. even observed higher case 
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fatality rates in malaria-negative cases than in those who were positive and treated 
(Reyburn et al. 2004). On the other hand there is also data that indicates an 
increased use of antibiotics in case of negative test results (Ansah et al. 2010, 
Msellem et al. 2009).  
However, even in the future RDTs for malaria will not be able to exclude other 
diseases and implementation of additional diagnostic equipment requires money, 
expertise and time. Meanwhile, it is not much known about the real impact of 
bacterial bloodstream infections, but the existing figures let hypothesize that they 
cause a significant proportion of fever cases in SSA (Reddy et al. 2010). As well as 
typhoid fever, which is a common reason for hospital attendance (Lutterloh et al. 
2012, Marks et al. 2010, Neil et al. 2012), bacteraemia and septicaemia of other 
origin is often accompanied with overlapping symptoms to malaria (Brent et al. 2006). 
To be able to distinguish between certain conditions the treating health worker or 
physician must be familiar with the local epidemiology of diseases and their clinical 
presentations. As in countries where the seasons predefine the incidences for e.g. 
respiratory tract infections in the dry season and malaria and typhoid fever in the 
rainy season, distribution of disease differs between regions and countries.  
Therefore clinical algorithms as presented in this study can help to give an evident 
feedback of common clinical presentations and their association to a certain 
diseases.  
Aside from that, health workers indeed play a key role for correct assessment and 
treatment of children with malaria. They are frequently forced to decide about 
treatment under great pressure, because often children are presented to them only 
once, due to access barriers to hospitals such as long travel distances, costs or lack 
of health insurance coverage (Sarpong et al. 2010).  
As experiences with RDTs have shown translation of policies and their changes are 
not feasible without proper training and evidence based feedback (McMorrow et al. 
2008, Reyburn et al. 2007).  
For the future improved surveillance systems for disease epidemiology on a regional 
basis and intense training of health workers based on local experiences would be 
highly desirable. Continuous reviews of patients could lead to more conservative 
treatment strategies. Further it is necessary to keep on track with distribution of 
equipment for malaria and bacterial diseases diagnostics. 
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4.8 Limitations of this study  
The present study has some limitations, which need to be taken into account for 
interpretation of the results. 
Although the overall conditions in the Agogo Presbyterian Hospital were comparable 
to other settings in West Africa, the APH is involved in medical research for a longer 
period of time. It is well connected to surrounding villages and the population might 
be more open-minded for seeking professional medical help instead of visiting 
traditional healers as they or their relatives might have successfully participated in 
earlier studies. Another part of the present study revealed an average ‘symptom-to-
hospital-time’ of 3.8 days, which is very short compared to other studies (Gay-
Andrieu et al. 2005, Modiano et al. 1998) and could be an expression of good 
adherence of the population to conventional medicine. 
But, consequently, clinical presentations of patients included in this analysis might be 
also less severe and biased by a better health care seeking behavior in the present 
study population. 
Conditions with overlapping symptoms to malaria have been frequently described. 
Ideally it should have been possible to examine every child for potential coincidential 
diseases, but due to non-existing microbiological infrastructure and high costs for 
equipment this was not feasible and not part of the study. Further on, all signs and 
symptoms in the analysis were clearly related to and predictive values were 
calculated for the outcome ‘P. falciparum parasitaemia’. However, comparison with 
other studies that used ‘clinical malaria’ as primary endpoint may be difficult.  
 
4.9 Conclusion 
The present study revealed a clear age dependency of the predictive value of the 
symptoms fever and palmar pallor. The use of the age-derived CART-algorithm 
increases the specificity of the prediction for P.falciparum parasitaemia. The 
symptom palmar pallor is easy to recognize and might be helpful for health workers 
as an indicator not only for anaemia but also for malarial parasitaemia. Palmar pallor 
is able to indicate significant lower Hb-levels even in a population with a high 
prevalence of anaemia. Due to a lack of sensitivity neither the best algorithm nor 
palmar pallor as a single sign are eligible for decision-making and cannot replace 
laboratory diagnosis or the use of RDTs. Where these diagnostics are not available 




For the year 2009, the World Health Organization (WHO) estimated 225 million 
cases of malaria worldwide. Fifty-eight percent of all deaths on the African continent 
due to malaria were children under 5 years of age.  
As malaria incidences are reported to decline over the last years other conditions 
causing similar symptoms as clinical malaria are gaining in relevance. While 
laboratory equipment is often missing in resource poor settings presumptive 
treatment is still common, but the diagnosis of malaria is usually based on the 
personal experience of the treating health professional. This study aimed to generate 
an age-derived clinical algorithm with simple signs and symptoms for the diagnosis of 
P. falciparum parasitaemia. 
The study was conducted in a rural hospital in the Ashanti Region, Ghana, which is 
holoendemic for malaria throughout the year. In total, 5447 visits of 3641 patients 
between 2-60 months of age who attended the outpatient department (OPD) were 
analyzed. All children were clinically examined by a paediatrician and a full blood 
count and thick smear were done. A Classification and Regression Tree (CART) 
model was used to generate a clinical algorithm to predict malarial parasitaemia and 
predictive values of all symptoms were calculated. 
Malarial parasitaemia was detected in children between 2-12 months and between 
12-60 months of age with a prevalence of 13.8% and 30.6%, respectively. The CART 
revealed age-dependent differences in the ability of the variables to predict 
parasitaemia. While palmar pallor was the most important symptom in children 
between 2-12 months, a report of fever and an elevated body temperature of ≥ 
37.5°C gained in relevance in children between 12-60 months. The variable palmar 
pallor was significantly (p<0.001) associated with lower haemoglobin levels in 
children of all ages. Compared to the Integrated Management of Childhood Illness 
(IMCI) algorithm the CART had higher specificity and positive predictive values for a 
malarial parasitaemia.  
Use of age-derived algorithms can increase the specificity of the prediction for 
P.falciparum parasitaemia. The predictive value of palmar pallor is able to indicate 
significant lower haemoglobin - levels even in a population with a high prevalence of 
anaemia and should be therefore underlined in health worker training. Due to a lack 
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of sensitivity neither the best algorithm nor palmar pallor as a sign are eligible for 




Die Weltgesundheitsorganisation WHO schätzte die Zahl der anMalaria erkrankten 
Menschen im Jahr 2009 auf weltweit 225 Millionen. Auf dem afrikanischen Kontinent 
betrafen 85% der durch Malaria verursachten Todesfälle Kinder unter fünf Jahren. 
Obwohl die Inzidenzen der P.falciparum-Malaria in einigen Teilen des 
subsaharischen Afrika sinken und andere Erkrankungen mit ähnlichen Symptomen 
wie denen der Malaria an Bedeutung gewinnen, ist eine vorsorgliche medikamentöse 
Behandlung im Verdachtsfall weiterhin üblich. Ziel dieser Arbeit ist die Generierung 
eines auf das Lebensalter bezogenen klinischen Algorithmus, der mit einfachen 
klinischen Symptomen die Diagnose einer P.-falciparum-Parasitämie ermöglicht. 
Die Studie wurde in einem ländlichen Krankenhaus in der Ashanti-Region in Ghana 
durchgeführt, welche über das ganze Jahr hinweg holoendemisch für Malaria ist. 
Insgesamt wurden 5447 ambulante Besuche von 3641 Patienten im Alter zwischen 
2-60 Monaten analysiert. Alle Kinder wurden von einem Pädiater klinisch untersucht 
und es wurden ein kleines Blutbild sowie ein Malariaausstrich (‘Dicker Tropfen’) 
angefertigt. Mit Hilfe einesClassification and Regression Tree (CART) wurde ein 
klinischer Entscheidungsbaum für die Prädiktion einer Plasmodium-Parasitämie 
generiert und prädiktive Werte für alle erfassten Symptome berechnet. 
Eine Parasitämie wurde bei Kindern im Alter von 2-12 Monaten mit einer Prävalenz 
von 13.8% und bei Kindern im Alter zwischen 12 und 60 Monatenmit einer Prävalenz 
von 30.6% gefunden. Das CART-Modell ergab altersabhängige Unterschiede in der 
Fähigkeit der Variablen eine Parasitämie vorherzusagen. Während sich bei Kindern 
im Alter zwischen 2 und 12 Monaten die „palmare Blässe“ als das wichtigste 
Symptom herausstellte, gewannen die Variablen „Fieber in der Anamnese“ und 
„erhöhte Körpertemperatur ≥ 37.5°C“ bei Kindern im Alter zwischen 12 und 60 
Monaten an Bedeutung. Die Variable „palmare Blässe“ war bei Kindern jedes Alters 
signifikant (p<0.001) mit niedrigeren Hämoglobinwerten assoziiert. Im Vergleich 
zumAlgorithmus desIntegrated Management of Childhood Illness (IMCI) hatte das 
CART-Modell eine deutlich höhere Spezifität sowie einen höheren positiven 
prädiktiven Wert für die Vorhersage einer Parasitämie. 
 72 
Schlussfolgerung 
Die Anwendung von altersbezogenen Algorithmen erhöht die Spezifität der 
Vorhersage einerP.-falciparum-Parasitämie. Selbst in einer Population mit einer 
hohen Prävalenz an Anämie ermöglicht der prädiktive Wert der „palmaren Blässe“ 
eine Erkennung von signifikant geringeren Hb-Werten. Die Bedeutung der „palmaren 
Blässe“ sollte daher in der Schulung von Gesundheitshelfern hervorgehoben werden. 
Mangels ausreichender Sensitivität kann allerdings weder auf Basis des besten 
Algorithmus noch mit „palmarer Blässe“ als einzelnem klinischem Zeichen eine 
Therapieentscheidung getroffen werden. Sie sind daher kein Ersatz für eine 

































Table A1.  Re-occurence of palmar pallor in 1125 patients who had multiple visits 


















Table A2. Undernutritiona and wastingb among children in different ages 
 
 
Age in months Number of patients  
 -2SDc  (%) Mean 95% - CId 
     
Undernutritiona 2 - 12 (n=1295) 132 (10.19) -0.41 (-0.48) - (-0.34) 
 12 - 24 (n=1412) 168 (11.90) -0.75 (-0.81) - (-0.69) 
 24 - 36 (n=1286) 141 (10.96) -0.83 (-0.88) - (-0.77) 
 36 – 48 (n=807) 84 (10.41) -0.83 (-0.90) - (-0.76) 
 48 – 60 (n=621) 103 (16.59) -1.08 (-1.15) - (-1.00) 
     
Wastingb 2 - 12 (n=1245) 150 (12.05) -0.44 (-0.53) - (-0.36) 
 12 - 24 (n=1375) 175 (12.73) -0.77 (-0.83) - (-0.71) 
 24 - 36 (n=1254) 101 (8.05) -0.60 (-0.66) - (-0.54) 
 36 – 48 (n=783) 41 (5.24) -0.53 (-0.60) - (-0.46) 
 48 – 60 (n=593) 62 (10.46) -0.80 (-0.89) - (-0.71) 
 
a Undernutrition:  2 standard deviations below the median weight-for-age z-score 
b Wasting:  2 SDs below the median weight-for-height z-score 
c
2 standard deviations below the corresponding mean of the certain variable 




on first visit 
Pallor on subsequent visit Total 
 No Yes  
No 2662 (95.8%) 117 (4.2%) 2779 (100%) 
    
Yes 132 (86.8%) 20 (13.2%) 152 (100%) 
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Table A3. Correlation between presence of palmar pallor and lower weight-for-age  
                  z-scoresa in patients of different ages 
 
Age of patients 
(months) 
Weight-for-age z-scorea (mean) p-valueb 
 Palmar pallor not present Palmar pallor present  
    
  2 – 12  -0.38 [CI: (-0.45) – (-0.31)] -0.82 [CI: (-1.13) – (-0.50)]   0.001 
12 – 60  -0.81 [CI: (-0.85) – (-0.78)] -1.11 [CI: (-1.22) – (-1.00)] <0.001 
  2 – 60  -0.71 [CI: (-0.74) – (-0.68)] -1.06 [CI: (-1.17) – (-0.95)] <0.001 
    
a Weight-for-age z-score was calculated to estimate the grade of undernutrition 
b The p-value was calculated by assuming a Students distribution and t-testing the 
hypothesis that there is no difference of the mean weight-for-age z-score between patients 
with and those without palmar pallor.   


































Figure A1.  CART for the first visit* of children between 2 and 12 months 







CART was calculated only for the first visit of each individual. Subsequent visits of   
  individuals were excluded from the analysis. 
1 Number of patients with therespective combination of variables given by the branches of 
  the decision tree 
2 Number of patients positive for P. falciparumparasitaemia 
3 Odds Ratio for P. falciparumparasitaemiawith the combination of variables in comparison  
































Figure A2.  CART for the first visit* of children between 12 and 60 months 




CART was calculated only for the first visit of each individual. Subsequent visits of   
  individuals were excluded from the analysis. 
1 Number of patients with therespective combination of variables given by the branches of 
  the decision tree 
2 Number of patients positive for P. falciparumparasitaemia 
3 Odds Ratio for P. falciparumparasitaemiawith the combination of variables in comparison 
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